Klarna Group plc (NYSE: KLAR) outlines losses, $13B deposits and AI, credit risks
Klarna Group plc filed its annual Form 20-F, outlining how its growth-focused business model, funding structure and risk profile are evolving. The company highlights a shift from long profitability to recent volatility, with a net profit of
Klarna emphasizes reliance on consumer deposits for funding: in the year ended
The filing details extensive risks: dependence on merchant relationships and brand, intense competition from banks, card networks and fintechs, regulatory and licensing complexity across jurisdictions, heavy use of AI and ML with emerging legal requirements such as the EU AI Act and GDPR, unsecured consumer credit exposure of
Positive
- None.
Negative
- None.
Insights
High-growth Klarna leans on deposits and underwriting to manage rising risk and earnings volatility.
Klarna positions itself as a global commerce and payments platform, but this filing underscores a classic high-growth, high-risk profile. Rapid U.S. and multi-market expansion has produced strong GMV gains but uneven profitability, with swings between modest profit and sizable net losses.
The business model now depends heavily on consumer deposits—
Risk disclosures around AI, data privacy and evolving EU/UK regulation (including the AI Act and GDPR interpretations) highlight growing compliance complexity. Execution on geographic expansion, advertising monetization and partnerships with banks, card networks and cloud providers will be critical; any misstep in underwriting performance, funding access or regulatory alignment could quickly affect margins and capital flexibility.
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 |
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Ordinary shares, nominal value $0.0001 per share |
N/A | ||
(Title of class) |
N/A | ||
(Title of class) |
Large accelerated filer | o | Accelerated filer | o | |
x | Emerging growth company |
U.S. GAAP | o | by the International Accounting Standards Board | x | Other | o |
Page | ||
Part I | ||
Item 1. Identity of Directors, Senior Management and Advisers | 1 | |
Item 2. Offer Statistics and Expected Timetable | 2 | |
Item 3. Key Information | 3 | |
Item 4. Information on the Company | 77 | |
Item 4A. Unresolved Staff Comments | 130 | |
Item 5. Operating and Financial Review and Prospects | 130 | |
Item 6. Directors, Senior Management and Employees | 201 | |
Item 7. Major Shareholders and Related Party Transactions | 214 | |
Item 8. Financial Information | 217 | |
Item 9. The Offer and Listing | 218 | |
Item 10. Additional Information | 219 | |
Item 11. Quantitative and Qualitative Disclosures About Market Risk | 239 | |
Item 12. Description of Securities Other than Equity Securities | 244 | |
Part II | ||
Item 13. Defaults, Dividend Arrearages and Delinquencies | 245 | |
Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds | 246 | |
Item 15. Controls and Procedures | 247 | |
Item 16. [Reserved] | 248 | |
Item 16A. Audit committee financial expert | 248 | |
Item 16B. Code of Ethics | 248 | |
Item 16C. Principal Accountant Fees and Services | 248 | |
Item 16D. Exemptions from the Listing Standards for Audit Committees | 249 | |
Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers | 249 | |
Item 16F. Change in Registrant's Certifying Accountant | 249 | |
Item 16G. Corporate Governance | 249 | |
Item 16H. Mine Safety Disclosure | 252 | |
Item 16L. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections | 252 | |
Item 16J. Insider trading policies | 252 | |
Item 16K. Cybersecurity | 252 | |
Part III | ||
Item 17. Financial Statements | 254 | |
Item 18. Financial Statements | 255 | |
Item 19. Exhibits | 255 | |
Signatures | 257 | |
Glossary of terms | 258 | |
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS | F-1 | |






![]() | |||||||||||||
2020 | 2021 | 2022 | 2023 | 2024 | |||||||||
![]() | |||||||||||||
Share of checkout** | 12% | 15% | 35% | 30%* | 32% | ||||||||
GMV vs. 2020 | 1x | 2x | 2x | 3x | 5x | ||||||||
Revenue vs. 2020 | 1x | 2x | 2x | 4x | 9x | ||||||||







Location | Type | Ownership | Size (in sq. feet) | |||
Stockholm, Sweden .......................................................................................... | Office | Leased | 189,714 | |||
Berlin, Germany ................................................................................................. | Office | Leased | 83,733 | |||
Giessen, Germany ............................................................................................. | Office | Leased | 48,491 | |||
Munich, Germany .............................................................................................. | Office | Leased | 35,725 | |||
Total .................................................................................................................... | 357,663 |
For the Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
(in $ millions) | |||||
Revenue: | |||||
Transaction and service revenue ................................................................... | 2,500 | 2,136 | 1,768 | ||
Gain on sale of consumer receivables .......................................................... | 73 | — | — | ||
Interest income .................................................................................................. | 937 | 675 | 508 | ||
Total revenue ....................................................................................................... | 3,509 | 2,811 | 2,276 | ||
Processing and servicing costs ....................................................................... | (809) | (596) | (541) | ||
Provision for credit losses ................................................................................ | (794) | (495) | (353) | ||
Funding costs ...................................................................................................... | (667) | (503) | (297) | ||
Technology and product development ......................................................... | (486) | (444) | (389) | ||
Sales and marketing .......................................................................................... | (414) | (328) | (381) | ||
Customer service and operations .................................................................. | (207) | (203) | (240) | ||
General and administrative .............................................................................. | (306) | (281) | (270) | ||
Depreciation, amortization and impairments .............................................. | (55) | (82) | (128) | ||
Total operating expenses .................................................................................. | (3,739) | (2,932) | (2,599) | ||
Operating loss .................................................................................................... | (230) | (121) | (323) | ||
Other income (expense) ................................................................................... | (11) | 154 | 19 | ||
Profit (loss) before taxes .................................................................................... | (241) | 33 | (304) | ||
Tax (expense) benefit ....................................................................................... | (32) | (12) | 60 | ||
Net profit (loss) .................................................................................................... | (273) | 21 | (244) | ||
% Change on a Like-for-Like basis 1 | |||||||||
2025 | 2024 | $ Change | % Change | ||||||
(in $ millions, except for percentages) | |||||||||
Transaction and service revenue ...... | 2,500 | 2,136 | 364 | 17% | 17% | ||||
Gain on sale of consumer receivables ............................................. | 73 | — | 73 | n.m. | n.m. | ||||
Interest income ...................................... | 937 | 675 | 262 | 39% | 34% | ||||
Total revenue ......................................... | 3,509 | 2,811 | 698 | 25% | 24% | ||||
Year Ended December 31, | |||||||
2025 | 2024 | $ Change | % Change | ||||
(in $ millions, except for percentages) | |||||||
Processing and servicing costs ........................................ | (809) | (596) | (213) | 36% | |||
Provision for credit losses ................................................. | (794) | (495) | (299) | 60% | |||
Funding costs ....................................................................... | (667) | (503) | (164) | 33% | |||
Technology and product development .......................... | (486) | (444) | (43) | 10% | |||
Sales and marketing ............................................................ | (414) | (328) | (87) | 26% | |||
Customer service and operations .................................... | (207) | (203) | (4) | 2% | |||
General and administrative ............................................... | (306) | (281) | (25) | 9% | |||
Depreciation, amortization and impairments ................ | (55) | (82) | 28 | (34)% | |||
Operating expenses .............................................................. | (3,739) | (2,932) | $(807) | 28% | |||
Year Ended December 31, | |||||||
2024 | 2023 | $ Change | % Change | ||||
(in $ millions, except for percentages) | |||||||
Processing and servicing costs ........................................ | (596) | (541) | (55) | 10% | |||
Provision for credit losses ................................................. | (495) | (353) | (143) | 40% | |||
Funding costs ....................................................................... | (503) | (297) | (207) | 70% | |||
Technology and product development .......................... | (444) | (389) | (54) | 14% | |||
Sales and marketing ............................................................ | (328) | (381) | 53 | (14)% | |||
Customer service and operations .................................... | (203) | (240) | 37 | (15)% | |||
General and administrative ............................................... | (281) | (270) | (11) | 4% | |||
Depreciation, amortization and impairments ................ | (82) | (128) | 46 | (36)% | |||
Operating expenses .............................................................. | (2,932) | (2,599) | $(333) | 13% | |||
For the Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Transaction Margin Dollars .............................................................................. | $1,238 | $1,217 | $1,085 | |||
Transaction Margin ........................................................................................... | 35% | 43% | 48% | |||
Adjusted Operating Profit (Loss) .................................................................... | $65 | $181 | $(49) | |||
Adjusted Operating Margin ............................................................................. | 1.9% | 6.4% | (2.2)% | |||
For the Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Total revenue ..................................................................................................... | $3,509 | $2,811 | $2,276 | |||
Operating loss .................................................................................................... | $(230) | $(121) | $(323) | |||
Operating margin .............................................................................................. | (6.6)% | (4.3)% | (14.2)% | |||
Adjustments: | ||||||
Technology and product development ....................................................... | $486 | $444 | $389 | |||
Sales and marketing ......................................................................................... | $414 | $328 | $381 | |||
Customer service and operations ................................................................. | $207 | $203 | $240 | |||
General and administrative ............................................................................ | $306 | $281 | $270 | |||
Depreciation, amortization (excluding software) and impairments ...... | $55 | $82 | $128 | |||
Transaction margin dollars ............................................................................... | $1,238 | $1,217 | $1,085 | |||
Transaction margin ............................................................................................ | 35.3% | 43.3% | 47.7% | |||
For the Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Total revenue ..................................................................................................... | $3,509 | $2,811 | $2,276 | |||
Operating loss ................................................................................................... | $(230) | $(121) | $(323) | |||
Operating margin .............................................................................................. | (6.6)% | (4.3)% | (14.2)% | |||
Adjustments: | ||||||
Depreciation, amortization and impairments ............................................. | $106 | $189 | $227 | |||
Share-based payments expense .................................................................. | $156 | $93 | $43 | |||
Severance-related restructuring costs ........................................................ | $15 | $6 | $4 | |||
IPO-related costs ............................................................................................. | $17 | $14 | $— | |||
Adjusted operating profit (loss) .................................................................... | $65 | $181 | $(49) | |||
Adjusted operating margin ............................................................................. | 1.9% | 6.4% | (2.1)% | |||
For the Year Ended December 31, | % Change | |||||
2025 | 2024 | |||||
Revenue | ||||||
Transaction and service revenue (as reported) ....................................... | $2,500 | $2,136 | 17% | |||
Impact of KCO disposition .............................................................................. | N/A | $(62) | N/A | |||
Impact of foreign currency translation ........................................................ | $(73) | $— | N/A | |||
Transaction and service revenue (like-for-like basis) ............................. | $2,427 | $2,074 | 17% | |||
Gain on sale of consumer receivables (as reported) ................................ | $73 | N/A | N/A | |||
Impact of KCO disposition .............................................................................. | N/A | N/A | N/A | |||
Impact of foreign currency translation ........................................................ | $(2) | N/A | N/A | |||
Gain on sale of consumer receivables (like-for-like basis) ..................... | $71 | N/A | N/A | |||
Interest income (as reported) ....................................................................... | $937 | $675 | 39% | |||
Impact of KCO disposition .............................................................................. | N/A | N/A | N/A | |||
Impact of foreign currency translation ........................................................ | $(2) | $— | N/A | |||
Interest revenue (like-for-like basis) ............................................................ | $935 | $675 | 39% | |||
Total revenue (as reported) ........................................................................... | $3,509 | $2,811 | 25% | |||
Total revenue (like-for-like basis) ................................................................. | $3,433 | $2,749 | 25% | |||
Transaction margin dollars | ||||||
Transaction margin dollars (as reported) ................................................... | $1,238 | $1,217 | 2% | |||
Impact of KCO disposition .............................................................................. | $— | $(43) | (100)% | |||
Impact of foreign currency translation ........................................................ | $47 | $— | N/A | |||
Transaction margin dollars (like-for-like basis) ......................................... | $1,285 | $1,174 | 9% | |||
Three Months Ended | |||||||||||||||||||||||
Q1 | Q2 | Q3 | Q4 | Q1 | Q2 | Q3 | Q4 | Q1 | Q2 | Q3 | Q4 | ||||||||||||
March 31, 2023 | June 30, 2023 | September 30, 2023 | December 31, 2023 | March 31, 2024 | June 30, 2024 | September 30, 2024 | December 31, 2024 | March 31, 2025 | June 30, 2025 | September 30, 2025 | December 31, 2025 | ||||||||||||
(in $ millions) | |||||||||||||||||||||||
Revenue: | |||||||||||||||||||||||
Transaction and service revenue ........ | 368 | 418 | 441 | 541 | 486 | 518 | 532 | 600 | 519 | 604 | 634 | 743 | |||||||||||
Gain on sale of consumer receivables ................. | – | – | – | – | – | – | – | – | – | – | – | 73 | |||||||||||
Interest income ......... | 116 | 116 | 134 | 142 | 157 | 164 | 173 | 181 | 182 | 219 | 269 | 267 | |||||||||||
Total revenue ............. | 484 | 534 | 575 | 683 | 643 | 682 | 705 | 781 | 701 | 823 | 903 | 1,082 | |||||||||||
Processing and servicing costs ........... | (128) | (131) | (133) | (149) | (136) | (148) | (151) | (161) | (164) | (187) | (208) | (250) | |||||||||||
Provision for credit losses .......................... | (73) | (88) | (72) | (120) | (117) | (106) | (116) | (156) | (136) | (174) | (235) | (250) | |||||||||||
Funding costs ............ | (57) | (62) | (78) | (100) | (113) | (120) | (123) | (147) | (130) | (147) | (180) | (210) | |||||||||||
Technology and product development .............. | (88) | (95) | (91) | (115) | (99) | (103) | (107) | (135) | (115) | (120) | (123) | (128) | |||||||||||
Sales and marketing . | (76) | (86) | (81) | (138) | (79) | (78) | (70) | (101) | (91) | (93) | (102) | (128) | |||||||||||
Customer service and operations .......... | (63) | (54) | (53) | (70) | (57) | (48) | (44) | (54) | (51) | (51) | (53) | (52) | |||||||||||
General and administrative ............ | (64) | (63) | (53) | (90) | (51) | (64) | (65) | (101) | (94) | (65) | (77) | (70) | |||||||||||
Depreciation, amortization and impairments ............... | (37) | (33) | (18) | (40) | (19) | (19) | (17) | (27) | (10) | (32) | (8) | (4) | |||||||||||
Total operating expenses .................... | (586) | (612) | (579) | (822) | (671) | (686) | (693) | (882) | (791) | (869) | (986) | (1,093) | |||||||||||
Operating profit (loss) | (102) | (78) | (4) | (139) | (28) | (4) | 12 | (101) | (90) | (46) | (83) | (11) | |||||||||||
Other income (expense) ................... | 4 | (4) | 8 | 11 | 3 | 2 | 2 | 147 | (2) | — | (4) | (5) | |||||||||||
Profit (loss) before income taxes ............. | (98) | (82) | 4 | (128) | (25) | (2) | 14 | 46 | (92) | (46) | (87) | (16) | |||||||||||
Tax benefit | 55 | (10) | — | 15 | (5) | (2) | (6) | (7) | (7) | (8) | (10) | ||||||||||||
Net profit (loss) .......... | (43) | (92) | 4 | (113) | (30) | (2) | 12 | 40 | (99) | (53) | (95) | (26) | |||||||||||
As of December 31, | ||||||
2025 | 2024 | 2023 | ||||
Own funds: | ||||||
CET1 capital ...................................................................................................... | 1,583 | 1,176 | 1,159 | |||
Tier 1 capital ..................................................................................................... | 1,764 | 1,326 | 1,176 | |||
Total capital ..................................................................................................... | 1,947 | 1,497 | 1,251 | |||
Total risk-weighted exposure amount ......................................................... | 10,062 | 6,986 | 7,150 | |||
Capital ratios and requirements: (1) | ||||||
CET1 capital requirement .............................................................................. | 8.6% | 8.6% | 8.6% | |||
CET1 capital ratio ............................................................................................ | 15.7% | 16.8% | 16.2% | |||
Tier 1 capital requirement ............................................................................. | 10.3% | 10.3% | 10.4% | |||
Tier 1 capital ratio ........................................................................................... | 17.5% | 19.0% | 16.4% | |||
Overall capital requirement .......................................................................... | 12.5% | 12.6% | 12.4% | |||
Total capital ratio ............................................................................................ | 19.4% | 21.4% | 17.5% | |||
Leverage ratio and requirements: | ||||||
Total leverage ratio exposure amount ....................................................... | 18,717 | 13,371 | 13,130 | |||
Leverage ratio requirement (2) ..................................................................... | 5.3% | 5.3% | 6.0% | |||
Leverage ratio (3) ............................................................................................. | 9.4% | 9.9% | 9.0% | |||
Liquidity coverage ratio (LCR): (4) | ||||||
HQLA ................................................................................................................. | 4,543 | 3,143 | 2,909 | |||
LCR .................................................................................................................... | 891.9% | 570.9% | 723.6% | |||
Net Stable Funding Ratio (NSFR): (5) | ||||||
Total available stable funding ...................................................................... | 14,296 | 10,749 | 11,702 | |||
Total required stable funding ....................................................................... | 7,423 | 6,014 | 5,974 | |||
NSFR .................................................................................................................. | 192.6% | 178.7% | 195.9% | |||
For the Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Cash provided by (used in): | ||||||
Operating activities .......................................................................................... | $(1,032) | $587 | $808 | |||
Investing activities ............................................................................................ | $(30) | $154 | $(83) | |||
Financing activities ........................................................................................... | $988 | $312 | $(62) | |||
Notes | Maturity Year | Interest Rate | Program | Outstanding Indebtedness | ||||
Senior Unsecured Floating Rate Notes ..................................... | 2026 | Three-month STIBOR plus 2.250% | Swedish Medium Term Note Program | $54.3 million | ||||
Senior Unsecured Floating Rate Notes ..................................... | 2026 | Three-month STIBOR plus 1.800% | Swedish Medium Term Note Program | $81.5 million | ||||
Senior Unsecured Floating Rate Notes ..................................... | 2027 | Three-month STIBOR plus 2.050% | Swedish Medium Term Note Program | $27.2 million | ||||
Senior Preferred Floating Rate Notes ........................................ | 2027 | Three-month STIBOR plus 1.550% | Euro Medium Term Note Program | $65.2 million | ||||
Senior Preferred Floating Rate Notes ........................................ | 2028 | Three-month STIBOR plus 1.750% | Euro Medium Term Note Program | $97.8 million | ||||
Tier 2 Subordinated Unsecured Floating Rate Notes ............. | 2033 | Three-month STIBOR plus 7.500% | N/A | $54.3 million | ||||
Tier 2 Subordinated Unsecured Floating Rate Notes ............. | 2033 | Three-month STIBOR plus 7.500% | N/A | $27.2 million | ||||
Tier 2 Subordinated Unsecured Floating Rate Notes ............. | 2034 | SOFR plus 7.000% | Euro Medium Term Note Program | $100.0 million | ||||
AT1 Subordinated Unsecured Floating Rate Notes ................ | No maturity | Three-month STIBOR plus 7.000% | N/A | $30.0 million | ||||
AT1 Subordinated Unsecured Floating Rate Notes ................ | No maturity | Three-month STIBOR plus 9.500% | N/A | $162.9 million | ||||
Total .................................................................................................. | $700.4 million |
Payments Due by Period | ||||||||
Contractual Obligations1 | Total | < 1 year | 1-5 years | > 5 years | ||||
(in $ million) | ||||||||
Consumer deposits ............................................................ | $13,337 | $11,043 | $2,294 | $— | ||||
Notes payable and other borrowings ........................... | 1,565 | 450 | 876 | 240 | ||||
Lease liabilities ................................................................... | 85 | 26 | 54 | 5 | ||||
Total ...................................................................................... | $14,987 | $11,518 | $3,224 | $245 | ||||


As of, or for the Year Ended, December 31, | |||||
2025 | 2024 | 2023 | |||
GMV (in $ millions) ............................................................................................... | 127,862 | 105,015 | 92,465 | ||
Year-over-year change (in %) .......................................................................... | 22% | 14% | N/A | ||
Year-over-year change on a like-for-like basis* (in %) .............................. | 20% | 15% | N/A | ||
Number of Active Klarna Consumers (in millions)1 ........................................... | 118 | 93 | 84 | ||
Year-over-year change (in %) .......................................................................... | 27% | 11% | N/A | ||
ARPAC (in $)2 ........................................................................................................ | 29 | 30 | 27 | ||
Year-over-year change (in %) .......................................................................... | (3)% | 11% | N/A | ||
Year-over-year change on a like-for-like basis* (in %) .............................. | (2)% | 13% | N/A | ||
Transaction Margin Dollars (in $ millions)3 ........................................................ | 1,238 | 1,217 | 1,085 | ||
Year-over-year change (in %) .......................................................................... | 2% | 12% | N/A | ||
Year-over-year change on a like-for-like basis* (in %) .............................. | 9% | 15% | N/A | ||

For the Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
Total (in $ millions) ............................................................................................... | 127,862 | 105,015 | 92,465 | ||
Merchant checkout (in $ millions) .................................................................... | 112,916 | 95,623 | 84,642 | ||
as share of total GMV (in %) ............................................................................. | 88% | 91% | 92% | ||
Direct-to-consumer (in $ millions) .................................................................... | 14,946 | 9,392 | 7,823 | ||
as share of total GMV (in %) ............................................................................. | 12% | 9% | 8% | ||
For the Year Ended December 31, | |||||
2025 | 2024 | 2023 | |||
Pay in Full ............................................................................................................. | 11% | 16% | 21% | ||
Pay Later .............................................................................................................. | 80% | 79% | 75% | ||
Fair Financing ...................................................................................................... | 9% | 5% | 4% | ||

New Cohort Purchase Frequency Accelerating Faster than Older Cohorts |
![]() |


For the Year Ended December 31, | 2023 to 2025 % Change | ||||||
2025 | 2024 | 2023 | |||||
Processing and servicing costs ........................................ | $(809) | $(596) | $(541) | 50% | |||
Provision for credit losses ................................................. | (794) | (495) | (353) | 125% | |||
Funding costs ....................................................................... | (667) | (503) | (297) | 125% | |||
Total ....................................................................................... | $(2,270) | $(1,594) | $(1,191) | 91% | |||


Purchase Frequency by Cohort | Expanding Purchase Frequency | |
![]() | ![]() |














Pay Later Receivables | 24'Q4 | 25'Q3 | 25'Q4 |
Gross Carrying Amount | 5,388 | 5,793 | 6,347 |
Allowance for ECL | 201 | 242 | 220 |
ECL (% of Gross Carrying Amount) | 3.7% | 4.2% | 3.5% |






Financing Receivables | 24'Q4 | 25'Q3 | 25'Q4 |
Gross Carrying Amount | 3,085 | 4,793 | 4,604 |
Allowance for ECL | 131 | 249 | 272 |
ECL (% of Gross Carrying Amount) | 4.2% | 5.2% | 5.9% |
For the Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Pay in Full .................................................................................................... | 11% | 16% | 21% | |||
Pay Later .................................................................................................... | 80% | 79% | 75% | |||
Fair Financing ............................................................................................. | 9% | 5% | 4% | |||
Year ended December 31, | |||||||||||||||||
2025 | 2024 | 2023 | |||||||||||||||
(in $ millions, except for percentages) | Average balance | Interest | Average yield/ rate (in %) | Average balance | Interest | Average yield/ rate (in %) | Average balance | Interest | Average yield/ rate (in %) | ||||||||
Assets | |||||||||||||||||
Interest-earning deposits with banks | |||||||||||||||||
Domestic .................................... | $175 | $3 | 1.45% | $132 | $1 | 0.76% | $128 | $1 | 1.10% | ||||||||
International .............................. | 325 | 7 | 2.23% | 328 | 5 | 1.53% | 243 | 1 | 0.49% | ||||||||
Central bank funds sold | |||||||||||||||||
Domestic .................................... | 0 | 0 | 0.00% | 0 | 0 | 0.00% | 0 | 0 | 0.00% | ||||||||
International .............................. | 4,526 | 75 | 1.66% | 3,284 | 108 | 3.30% | 2,036 | 45 | 2.21% | ||||||||
Securities purchased with agreements to resell | |||||||||||||||||
Domestic .................................... | 0 | 0 | 0.00% | 0 | 0 | 0.00% | 0 | 0 | 0.00% | ||||||||
International .............................. | 15 | 0 | 1.97% | 0 | 0 | 0.00% | 0 | 0 | 0.00% | ||||||||
Loans | |||||||||||||||||
Domestic .................................... | 0 | 0 | 0.00% | 0 | 0 | 0.00% | 0 | 0 | 0.00% | ||||||||
International .............................. | 3,749 | 803 | 21.30% | 2,667 | 531 | 19.90% | 2,424 | 434 | 17.91% | ||||||||
Taxable investment securities | |||||||||||||||||
Domestic .................................... | 0 | 0 | 0.00% | 0 | 0 | 0.00% | 0 | 0 | 0.00% | ||||||||
International .............................. | 1,228 | 49 | 3.98% | 805 | 27 | 3.36% | 983 | 22 | 2.21% | ||||||||
Nontaxable investment securities | |||||||||||||||||
Domestic .................................... | 0 | 0 | 0.00% | 0 | 0 | 0.00% | 0 | 0 | 0.00% | ||||||||
International .............................. | 0 | 0 | 0.00% | 0 | 0 | 0.00% | 0 | 0 | 0.00% | ||||||||
Year ended December 31, | |||||||||||||||||
2025 | 2024 | 2023 | |||||||||||||||
(in $ millions, except for percentages) | Average balance | Interest | Average yield/ rate (in %) | Average balance | Interest | Average yield/ rate (in %) | Average balance | Interest | Average yield/ rate (in %) | ||||||||
Other short-term investments | |||||||||||||||||
Domestic .................................... | 0 | 0 | 0.00% | 0 | 0 | 0.00% | 0 | 0 | 0.00% | ||||||||
International .............................. | 6 | 0 | 2.55% | 4 | 0 | 1.58% | 1 | 0 | 1.38% | ||||||||
Total interest-earning assets .. | $10,023 | $937 | 9.35% | $7,220 | $672 | 9.31% | $5,815 | $503 | 8.66% | ||||||||
Domestic .................................... | 175 | 2 | 1.35% | 132 | 1 | 0.76% | 128 | 1 | 1.10% | ||||||||
International .............................. | 9,847 | 935 | 9.49% | 7,088 | 671 | 9.47% | 5,687 | 502 | 8.83% | ||||||||
All other assets | 7,620 | 0 | 0.00% | 7,200 | 0 | 0.00% | 6,512 | 0 | 0.00% | ||||||||
Domestic .................................... | 1,008 | 0 | 0.00% | 496 | 0 | 0.00% | 341 | 0 | 0.00% | ||||||||
International .............................. | 6,613 | 0 | 0.00% | 6,704 | 0 | 0.00% | 6,171 | 0 | 0.00% | ||||||||
Total domestic assets .............. | $1,183 | $2 | 0.20% | $628 | $1 | 0.16% | $469 | $1 | 0.30% | ||||||||
Total international assets ........ | 16,460 | 935 | 5.68% | 13,792 | 671 | 4.87% | 11,858 | 502 | 4.23% | ||||||||
Total assets ............................... | $17,643 | $937 | 5.31% | $14,420 | $672 | 4.66% | $12,327 | $503 | 4.08% | ||||||||
Liabilities | |||||||||||||||||
Savings deposits | |||||||||||||||||
Domestic .................................... | $2 | $0 | 0.00% | $0 | $0 | 0.00% | $0 | $0 | 0.00% | ||||||||
International .............................. | 12,392 | (347) | (2.80)% | 9,766 | (359) | (3.68)% | 7,910 | (203) | 2.57% | ||||||||
Other time deposits | |||||||||||||||||
Domestic .................................... | 0 | 0 | 0.00% | 0 | 0 | 0.00% | 0 | 0 | 0.00% | ||||||||
International .............................. | 0 | 0 | 0.00% | 0 | 0 | 0.00% | 0 | 0 | 0.00% | ||||||||
Central bank funds purchased | |||||||||||||||||
Domestic .................................... | 0 | 0 | 0.00% | 0 | 0 | 0.00% | 0 | 0 | 0.00% | ||||||||
International .............................. | 0 | 0 | 0.00% | 0 | 0 | 0.00% | 0 | 0 | 0.00% | ||||||||
Securities sold with agreements to repurchase | |||||||||||||||||
Domestic .................................... | 0 | 0 | 0.00% | 0 | 0 | 0.00% | 0 | 0 | 0.00% | ||||||||
International .............................. | — | 0 | 0.00% | 1 | 0 | (3.73)% | 21 | 0 | 0.72% | ||||||||
Commercial paper | |||||||||||||||||
Domestic .................................... | 0 | 0 | 0.00% | 0 | 0 | 0.00% | 0 | 0 | 0.00% | ||||||||
International .............................. | 46 | (1) | (2.68)% | 37 | (1) | (3.91)% | 20 | (1) | 5.01% | ||||||||
Other short-term debt | |||||||||||||||||
Domestic .................................... | 76 | (1) | (1.49)% | 87 | (1) | (1.33)% | 32 | (1) | 4.60% | ||||||||
International .............................. | 630 | (34) | (5.35)% | 442 | (20) | (4.55)% | 396 | (16) | 4.15% | ||||||||
Long-term debt | |||||||||||||||||
Domestic .................................... | 0 | 0 | 0.00% | 0 | 0 | 0.00% | 0 | 0 | 0.00% | ||||||||
International .............................. | 407 | (29) | (7.10)% | 226 | (22) | (9.92)% | 168 | (9) | 5.56% | ||||||||
Total interest-bearing liabilities ..................................... | $13,554 | $(412) | 3.04% | $10,559 | $(405) | 3.83% | $8,547 | $(230) | 2.71% | ||||||||
Domestic .................................... | 78 | (1) | 1.45% | 87 | (1) | 1.33% | 32 | (1) | 4.60% | ||||||||
International .............................. | 13,476 | (411) | 3.05% | 10,472 | (403) | 3.85% | 8,515 | (229) | 2.70% | ||||||||
All other liabilities | 1,605 | 0 | 0.00% | 1,556 | 0 | 0.00% | 1,499 | 0 | 0.00% | ||||||||
Domestic .................................... | 237 | 0 | 0.00% | 173 | 0 | 0.00% | 241 | 0 | 0.00% | ||||||||
International .............................. | 1,368 | 0 | 0.00% | 1,384 | 0 | 0.00% | 1,258 | 0 | 0.00% | ||||||||
Total domestic liabilities .......... | $315 | $(1) | 0.36% | $260 | $(1) | 0.45% | $273 | $(1) | 0.53% | ||||||||
Total international liabilities .... | 14,844 | (411) | 2.77% | 11,855 | (403) | 3.40% | 9,773 | (229) | 2.35% | ||||||||
Total liabilities ........................... | $15,159 | $(412) | 2.72% | $12,116 | $(405) | 3.34% | $10,046 | $(230) | 2.30% | ||||||||
2025 | For the year ended December 31, 2025 compared to the year ended December 31, 2024 | 2024 | For the year ended December 31, 2024 compared to the year ended December 31, 2023 | 2023 | |||||||||||||
(in $ millions, except for percentages) | Amount | Net change | Change due to volume | Change due to rate | Amount | Net change | Change due to volume | Change due to rate | Amount | ||||||||
Interest and similar income: | |||||||||||||||||
Interest-earning deposits with banks | |||||||||||||||||
Domestic .................................... | $2 | $1 | $0 | $0 | $1 | $0 | $0 | $0 | $1 | ||||||||
International .............................. | 7 | 2 | 0 | 2 | 5 | 4 | 0 | 3 | 1 | ||||||||
Central bank funds sold | |||||||||||||||||
Domestic .................................... | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
International .............................. | 75 | (33) | 29 | (62) | 108 | 63 | 28 | 36 | 45 | ||||||||
Securities sold with agreements to repurchase | |||||||||||||||||
Domestic .................................... | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
International .............................. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
Loans | |||||||||||||||||
Domestic .................................... | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
International .............................. | 798 | 267 | 114 | 152 | 532 | 98 | 44 | 54 | 434 | ||||||||
Taxable investment securities | |||||||||||||||||
Domestic .................................... | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
International .............................. | 49 | 19 | 6 | 14 | 29 | 3 | (5) | 8 | 27 | ||||||||
Nontaxable investment securities | |||||||||||||||||
Domestic .................................... | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
International .............................. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
Other short-term investments | |||||||||||||||||
Domestic .................................... | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
International .............................. | |||||||||||||||||
Total domestic interest and similar income ........................... | $2 | $0 | $0 | $0 | $1 | $0 | $0 | $0 | $1 | ||||||||
Total international interest and similar income .................... | $929 | $255 | $149 | $106 | $674 | $168 | $67 | $101 | $507 | ||||||||
Total interest and similar income ....................................... | $931 | $256 | $149 | $106 | $675 | $167 | $67 | $100 | $508 | ||||||||
Interest expense: | |||||||||||||||||
Savings deposits | |||||||||||||||||
Domestic .................................... | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | ||||||||
International .............................. | (348) | 12 | (37) | 49 | (360) | (155) | (69) | (86) | (205) | ||||||||
Other time deposits | |||||||||||||||||
Domestic .................................... | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
International .............................. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
Central bank funds purchased | |||||||||||||||||
Domestic .................................... | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
International .............................. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
Securities purchased with agreements to resell | |||||||||||||||||
Domestic .................................... | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
International .............................. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
Commercial paper | |||||||||||||||||
Domestic .................................... | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
2025 | For the year ended December 31, 2025 compared to the year ended December 31, 2024 | 2024 | For the year ended December 31, 2024 compared to the year ended December 31, 2023 | 2023 | |||||||||||||
(in $ millions, except for percentages) | Amount | Net change | Change due to volume | Change due to rate | Amount | Net change | Change due to volume | Change due to rate | Amount | ||||||||
International .............................. | (1) | 0 | (1) | 2 | (1) | 0 | (1) | 1 | (1) | ||||||||
Other short-term debt | |||||||||||||||||
Domestic .................................... | 0 | 1 | (1) | 2 | (1) | 0 | (1) | 2 | (1) | ||||||||
International .............................. | (34) | (11) | (23) | 11 | (23) | (1) | (21) | 20 | (21) | ||||||||
Long-term debt | |||||||||||||||||
Domestic .................................... | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||
International .............................. | (29) | (6) | (22) | 16 | (22) | (13) | (9) | (4) | (9) | ||||||||
Total domestic interest expense ..................................... | $0 | $1 | $(1) | $2 | $(1) | $0 | $(1) | $2 | $(1) | ||||||||
Total international interest expense ..................................... | $(412) | $(5) | $(83) | $78 | $(406) | $(170) | $(100) | $(69) | $(236) | ||||||||
Total interest expense ............. | $(412) | $(4) | $(84) | $80 | $(407) | $(169) | $(101) | $(67) | $(237) | ||||||||
Net change in net interest income ....................................... | $520 | $251 | $65 | $186 | $268 | $(2) | $(36) | $33 | $271 | ||||||||
Net interest income(1) ................ | $520 | $0 | $0 | $0 | $268 | $0 | $0 | $0 | $271 | ||||||||
Domestic .................................... | 1 | 0 | 0 | ||||||||||||||
International .............................. | 519 | 268 | 271 | ||||||||||||||
Net interest margin(2) ................. | 5.2% | 3.71% | 4.68% | ||||||||||||||
Domestic .................................... | 0.7% | (0.12)% | (0.04)% | ||||||||||||||
International .............................. | 5.3% | 3.78% | 4.8% | ||||||||||||||
(in $ millions, except for percentages) December 31, 2025 | < 1 year | 1-5 years | 5-10 years | > 10 years | Total | |||||||||||||||
Debt Security Category | Amount | Yield | Amount | Yield | Amount | Yield | Amount | Yield | Amount | Yield | ||||||||||
Central Banks ................ | $88 | 3.5% | $— | —% | $— | —% | $— | —% | $88 | 3.5% | ||||||||||
Governments ................. | 109 | 1.9% | 50 | 2.3% | — | — | — | — | 159 | 2.0 | ||||||||||
Municipalities ................ | 137 | 1.8% | 176 | 2.4% | — | — | — | — | 313 | 2.1 | ||||||||||
Supranationals .............. | 272 | 2.1% | 159 | 2.3% | — | — | — | — | 431 | 2.2 | ||||||||||
Covered Bonds ............. | —% | 58 | 2.5% | — | — | — | — | 58 | 2.5 | |||||||||||
Corporates ..................... | 134 | 2.0% | 335 | 2.5% | — | — | — | — | 469 | 2.4 | ||||||||||
Total ................................ | $740 | 2.0% | $778 | 2.4% | $— | —% | $— | —% | $1,518 | 2.2% | ||||||||||
(in $ millions, except for percentages) December 31, 2024 | < 1 year | 1-5 years | 5-10 years | > 10 years | Total | |||||||||||||||
Debt Security Category | Amount | Yield | Amount | Yield | Amount | Yield | Amount | Yield | Amount | Yield | ||||||||||
Central Banks ................ | $42 | 0.00% | $— | 0.00% | $— | —% | $— | —% | $42 | 0.00% | ||||||||||
Governments ................. | 12 | 0.17 | — | 0.00 | — | — | — | — | 12 | 0.17 | ||||||||||
Municipalities ................ | 144 | 0.21 | 40 | 1.09 | — | — | — | — | 185 | 0.40 | ||||||||||
Supranationals .............. | 140 | 1.65 | 66 | 0.53 | — | — | — | — | 206 | 1.29 | ||||||||||
Covered Bonds ............. | 9 | 0.36 | — | 0.00 | — | — | — | — | 9 | 0.36 | ||||||||||
Corporates ..................... | — | 0.00 | — | 0.00 | — | — | — | — | — | 0.00 | ||||||||||
Total ................................ | $347 | 0.77% | $106 | 0.74% | $— | —% | $— | —% | $454 | 0.76% | ||||||||||
(in $ millions) December 31, 2025 | ||||||||||
Consumer Loan Category | < 1 year | 1-5 years | 5-15 years | > 15 years | Total | |||||
Fair Financing ....................................... | $1,893 | $2,439 | $— | $— | $4,332 | |||||
Pay Later ................................................ | $6,127 | $— | — | — | 6,127 | |||||
Total ....................................................... | $8,020 | $2,439 | $— | $— | $10,459 |
(in $ millions) December 31, 2025 | |||||||||
Loan Category | < 1 year | 1-5 years | 5-15 years | > 15 years | Total | ||||
Fixed rate loans ..................................... | $8,020 | $2,439 | $— | $— | $10,459 | ||||
Floating or adjustable rate loans ....... | — | — | — | — | — | ||||
Total ......................................................... | $8,020 | $2,439 | $— | $— | $10,459 |
(in $ millions) December 31, 2024 | ||||||||||
Loan Category | < 1 year | 1-5 years | 5-15 years | > 15 years | Total | |||||
Consumer loans .................................... | $6,485 | $1,656 | $— | $— | $8,141 | |||||
Total ....................................................... | $6,485 | $1,656 | $— | $— | $8,141 |
(in $ millions) December 31, 2024 | ||||||||||
Loan Category | < 1 year | 1-5 years | 5-15 years | > 15 years | Total | |||||
Fixed rate loans .................................... | $6,485 | $1,656 | $— | $— | $8,141 | |||||
Floating or adjustable rate loans ...... | — | — | — | — | — | |||||
Total ....................................................... | $6,485 | $1,656 | $— | $— | $8,141 |
As of December 31, 2025 | |||||||||
(in $ millions, except for percentages) | Outstanding amount at end of period | Average outstanding amount during period | Allowance for credit losses at end of period | Ratio of allowance for credit losses to total loans outstanding | Ratio of net charge-offs to average loans outstanding during the period(1) | ||||
Fair Financing ......................................... | $4,604 | $3,845 | $(272) | (5.9)% | (6.5)% | ||||
Pay Later ................................................. | 6,347 | 5,868 | (220) | (3.5)% | (6.4)% | ||||
Total ......................................................... | $10,951 | $9,712 | $(492) | (4.5)% | (6.4)% | ||||
As of December 31, 2024 | |||||||||
(in $ millions, except for percentages) | Outstanding amount at end of period | Average outstanding amount during period | Allowance for credit losses at end of period | Ratio of allowance for credit losses to total loans outstanding | Ratio of net charge-offs to average loans outstanding during the period(1) | ||||
Consumer loans ..................................... | $8,473 | $8,434 | $(332) | (3.9)% | (5.5)% | ||||
Total ......................................................... | $8,473 | $8,434 | $(332) | (3.9)% | (5.5)% | ||||
As of December 31, 2023 | |||||||||
(in $ millions, except for percentages) | Outstanding amount at end of period | Average outstanding amount during period | Allowance for credit losses at end of period | Ratio of allowance for credit losses to total loans outstanding | Ratio of net charge-offs to average loans outstanding during the period(1) | ||||
Consumer loans ..................................... | $8,394 | $7,763 | $(311) | (3.7)% | (5.9)% | ||||
Total ......................................................... | $8,394 | $7,763 | $(311) | (3.7)% | (5.9)% | ||||
As of December 31, 2025 | |||||||
(in $ millions) | Balance | Foreign | Rate | Uninsured | |||
Consumer deposits ............................................................. | $13,003 | $13,003 | 2.4% | $681 | |||
Total ....................................................................................... | $13,003 | $13,003 | 2.4% | $681 | |||
As of December 31, 2024 | |||||||
(in $ millions) | Balance | Foreign | Rate | Uninsured | |||
Consumer deposits ............................................................. | $9,510 | $9,510 | 3.8% | $437 | |||
Total ....................................................................................... | $9,510 | $9,510 | 3.8% | $437 | |||
As of December 31, 2023 | |||||||
(in $ millions) | Balance | Foreign | Rate | Uninsured | |||
Consumer deposits ............................................................. | $9,478 | $9,478 | 2.4% | $320 | |||
Total ....................................................................................... | $9,478 | $9,478 | 2.4% | $320 | |||
As of December 31, | |||||
(in $ millions) | 2025 | 2024 | 2023 | ||
Germany ............................................................................................................... | $10,209 | $7,271 | $7,169 | ||
Sweden ................................................................................................................. | 643 | 752 | 1,114 | ||
Netherlands ......................................................................................................... | 1,774 | 1,306 | 1,054 | ||
Other countries .................................................................................................. | 377 | 181 | 141 | ||
Total ..................................................................................................................... | $13,003 | $9,510 | $9,478 | ||
As of December 31, | |||||
(in $ millions) | 2025 | 2024 | 2023 | ||
Klarna Bank AB ................................................................................................. | $7,679 | $5,746 | $6,475 | ||
Third-party platforms ...................................................................................... | 5,324 | 3,764 | 3,003 | ||
Total ................................................................................................................... | $13,003 | $9,510 | $9,478 | ||
Name | Age | Position(s) | ||
Executive Officers | ||||
Sebastian Siemiatkowski ............................................. | 43 | Chief Executive Officer and Director | ||
David Fock ....................................................................... | 47 | Chief Product and Design Officer | ||
Camilla Giesecke ........................................................... | 44 | Chief Operating Officer | ||
Niclas Neglén .................................................................. | 47 | Chief Financial Officer and Director | ||
David Sandström ............................................................ | 42 | Chief Marketing Officer | ||
Yaron Shaer .................................................................... | 49 | Chief Technology Officer | ||
David Sykes ..................................................................... | 41 | Chief Commercial Officer | ||
Non-Executive Directors | ||||
Michael J. Moritz ............................................................ | 70 | Chairperson of the Board of Directors | ||
Roger W. Ferguson, Jr. .................................................. | 73 | Director | ||
Lise Kaae ......................................................................... | 55 | Director | ||
Omid R. Kordestani ........................................................ | 61 | Director | ||
Andrew Reed .................................................................. | 35 | Director | ||
Sarah Smith ..................................................................... | 66 | Director | ||
Mateusz Staniszewski ................................................... | 30 | Director | ||
Markus Villig .................................................................... | 31 | Director |
(in $ millions) | Salary | Bonus | Fixed Equity | Variable equity | Other benefits | Pension expenses | Total |
Directors | |||||||
Michael J. Moritz | $0.1 | $— | $— | $1.5 | $— | $— | $1.6 |
Roger W. Ferguson, Jr. | $0.2 | $— | $0.1 | $0.2 | $— | $— | $0.4 |
Lise Kaae | $— | $— | $— | $1.5 | $— | $— | $1.5 |
Omid R. Kordestani | $0.2 | $— | $— | $0.2 | $— | $— | $0.4 |
Andrew Reed | $— | $— | $— | $1.5 | $— | $— | $1.5 |
Sarah Smith | $0.2 | $— | $— | $0.2 | $— | $— | $0.4 |
Markus Villig | $0.1 | $— | $— | $1.0 | $— | $— | $1.1 |
Mati Staniszewski | $0.1 | $— | $— | $1.0 | $— | $— | $1.1 |
Sebastian Siemiatkowski | $3.3 | $0.3 | $19.0 | $22.3 | $0.1 | $0.2 | $45.1 |
Niclas Neglén | $1.5 | $— | $2.4 | $4.2 | $— | $— | $8.1 |
Total .................................... | 5.7 | $0.3 | $21.4 | 33.5 | $0.1 | $0.2 | $61.1 |
Klarna Group plc RSU program | Share warrants and options issued by Klarna Group plc | Share options to acquire C Class shares2 issued by Klarna Group plc | |||||||||
Number | Weighted average fair value at grant | Number | Weighted average exercise price1 | Number | Weighted average exercise price | ||||||
December 31, 2024 ................. | — | $— | 6,100,140 | $46.0 | — | $— | |||||
Granted during the year ...... | 1,026,951 | 34.2 | 24,909,751 | 57.0 | 17,505,672 | 45.9 | |||||
Exercised during the year ... | — | — | (2,400,000) | — | — | — | |||||
Amended during the year 3 . | — | — | (1,477,164) | 38.2 | 2,941,236 | 19.1 | |||||
Forfeited during the year .... | (28,044) | 34.0 | — | — | — | — | |||||
December 31, 2025 ................. | 998,907 | $34.2 | 27,132,727 | $60.6 | 20,446,908 | $42.0 | |||||
Legacy RSU program | Share warrants issued by a subsidiary of Klarna Group plc | ||||||
Number | Weighted average fair value at grant | Number | Weighted average exercise price | ||||
December 31, 2024 ........................................................... | 26,411,646 | $4.5 | 2,507,534 | $543.0 | |||
Granted during the year ................................................. | 123,335 | 10.1 | — | — | |||
Released during the year ............................................... | (8,225,629) | 5.3 | — | — | |||
Exercised during the year .............................................. | — | — | (90,000) | 231.0 | |||
Repurchased during the year ....................................... | — | — | (105,646) | 441.0 | |||
Amended during the year .............................................. | — | — | — | — | |||
Forfeited during the year ............................................... | (3,712,137) | 5.0 | (84,367) | 631.0 | |||
December 31, 2025 ........................................................... | 14,597,215 | $5.1 | 2,227,521 | $605.0 | |||
Equivalent of Klarna Group plc Shares | 3,649,304 | $20.4 | 26,730,252 | $50.4 | |||

Shareholder | Number ordinary shares | Approximate % of Total Voting Rights |
Entities affiliated with Sequoia Capital1 | 76,671,503 | 23% |
Heartland A/S | 29,652,586 | 9% |
Victor Jacobsson | 24,959,959 | 6% |
Sebastian Siemiatkowski | 24,651,816 | 7% |
Commonwealth Bank of Australia | 17,407,235 | 5% |
Ordinary shares | Class B shares | Class C shares | Deferred shares | Deferred shares | Deferred shares | Deferred shares | |
Nominal value | $0.00010 | $0.00010 | $0.00010 | $0.00073 | $11.35013 | $0.28000 | $0.00010 |
As of January 01, 2024 | 364,018,908 | — | — | 364,018,908 | — | — | — |
Shares issued | 1,277,664 | — | — | 1,277,664 | — | 1 | — |
As of December 31, 2024 | 365,296,572 | — | — | 365,296,572 | — | 1 | — |
Shares issued | 12,211,338 | 369,911,294 | — | 257,772 | 369,911,294 | — | — |
Redesignation | (41,774,705) | 41,774,705 | |||||
Capital reduction | — | — | (365,554,344) | (369,911,294) | (1) | (41,774,705) | |
As of December 31, 2025 | 377,507,910 | 328,136,589 | — | — | — | — | — |
England and Wales | Delaware | |||
Number of Directors | Under the Companies Act, a public limited company must have at least two directors and the number of directors may be fixed by or in the manner provided in a company’s articles of association. | Under Delaware law, a corporation must have at least one director and the number of directors shall be fixed by or in the manner provided in the bylaws, unless the certificate of incorporation fixes the number of directors, in which case a change in the number of directors may be made only by amendment of the certificate of incorporation. |
Removal of Directors | Under the Companies Act, shareholders may remove a director without cause by an ordinary resolution (which is passed by a simple majority of those voting in person or by proxy at a general meeting) irrespective of any provisions of any service contract the director has with the company, provided 28 clear days’ notice of the resolution has been given to the company and its shareholders. On receipt of notice of an intended resolution to remove a director, the company must forthwith send a copy of the notice to the director concerned. Certain other procedural requirements under the Companies Act must also be followed, such as allowing the director to make representations against his or her removal either at the meeting or in writing. | Under Delaware law, any director or the entire board of directors may be removed, with or without cause, by the holders of a majority of the shares then entitled to vote at an election of directors, except (i) unless the certificate of incorporation provides otherwise, in the case of a corporation whose board of directors is classified, stockholders may effect such removal only for cause or (ii) in the case of a corporation having cumulative voting, if less than the entire board of directors is to be removed, no director may be removed without cause if the votes cast against his or her removal would be sufficient to elect him or her if then cumulatively voted at an election of the entire board of directors, or, if there are classes of directors, at an election of the class of directors of which he or she is a part. | ||
Vacancies on the Board of Directors | Under English law, the procedure by which directors, other than a company’s initial directors, are appointed is generally set out in a company’s articles of association, provided that where two or more persons are appointed as directors of a public limited company by resolution of the shareholders, resolutions appointing each director must be voted on individually. | Under Delaware law, vacancies and newly created directorships may be filled by a majority of the directors then in office (even though less than a quorum) or by a sole remaining director unless (i) otherwise provided in the certificate of incorporation or bylaws of the corporation or (ii) the certificate of incorporation directs that a particular class of stock is to elect such director, in which case a majority of the other directors elected by such class, or a sole remaining director elected by such class, will fill such vacancy. | ||
Annual General Meeting | Under the Companies Act, a public limited company must hold an annual general meeting in each six-month period following the company’s annual accounting reference date. | Under Delaware law, the annual meeting of stockholders shall be held at such place, on such date and at such time as may be designated from time to time by the board of directors or as provided in the certificate of incorporation or by the bylaws. | ||
General Meeting | Under the Companies Act, a general meeting of the shareholders of a public limited company may be called by the directors. Shareholders holding at least 5% of the paid-up capital of the company carrying voting rights at general meetings (excluding any paid-up capital held as treasury shares) can require the directors to call a general meeting and, if the directors fail to do so within a certain period, may themselves convene a general meeting. | Under Delaware law, special meetings of the stockholders may be called by the board of directors or by such person or persons as may be authorized by the certificate of incorporation or by the bylaws. |
Notice of General Meetings | Subject to a company’s articles of association providing for a longer period, under the Companies Act, (i) at least 21 days’ notice must be given for an annual general meeting and any resolutions to be proposed at the meeting and (ii) at least 14 days’ notice is required for any other general meeting of a public limited company. In addition, certain matters, such as the removal of directors or auditors, require special notice, which is 28 days’ notice. The shareholders of a company may in all cases consent to a shorter notice period, the proportion of shareholders’ consent required being 100% of those entitled to attend and vote in the case of an annual general meeting and, in the case of any other general meeting, a majority in number of the members having a right to attend and vote at the meeting, being a majority who together hold not less than 95% in nominal value of the shares giving a right to attend and vote at the meeting. | Under Delaware law, unless otherwise provided in the certificate of incorporation or bylaws, written notice of any meeting of the stockholders must be given to each stockholder entitled to vote at the meeting not less than 10 nor more than 60 days before the date of the meeting and shall specify the place, date and hour, the means of remote communications by which stockholders and proxy holders may be deemed present and may vote at the meeting, the record date for determining stockholders entitled to vote at the meeting (if different than the record date for determining stockholders entitled to notice) and, if the meeting is a special meeting, the purpose or purposes of the meeting. | ||
Quorum | Subject to the provisions of a company’s articles of association, the Companies Act provides that two shareholders present at a meeting (in person, by proxy or by authorized representative under the Companies Act) shall constitute a quorum for companies with more than one member. | The certificate of incorporation or bylaws may specify the number of shares, the holders of which shall be present or represented by proxy at any meeting in order to constitute a quorum, but in no event shall a quorum consist of less than one-third of the shares entitled to vote at the meeting. In the absence of such specification in the certificate of incorporation or bylaws, a majority of the shares entitled to vote, present in person or represented by proxy, shall constitute a quorum at a meeting of stockholders. | ||
Proxy | Under the Companies Act, at any meeting of shareholders, a shareholder may designate another person to attend, speak and vote at the meeting on their behalf by proxy. | Under Delaware law, at any meeting of stockholders, a stockholder may designate another person to act for such stockholder by proxy, but no such proxy shall be voted or acted upon after three years from its date, unless the proxy provides for a longer period. A director of a Delaware corporation may not issue a proxy representing the director’s voting rights as a director. | ||
Preemptive Rights | Under the Companies Act, “equity securities,” being (i) shares in the company other than shares that, with respect to dividends and capital, carry a right to participate only up to a specified amount in a distribution, referred to as “ordinary shares,” or (ii) rights to subscribe for, or to convert securities into, ordinary shares, proposed to be allotted for cash must be offered first to the existing holders of equity shares in the company in proportion to the respective nominal value of their holdings of ordinary shares, unless an exception applies or a special resolution to the contrary has been passed by shareholders in a general meeting or the articles of association provide otherwise in each case in accordance with the provisions of the Companies Act. | Under Delaware law, stockholders have no preemptive rights to subscribe to additional issues of stock or to any security convertible into such stock unless, and except to the extent that, such rights are expressly provided for in the certificate of incorporation. |
Liability of Directors and Officers | Under the Companies Act, any provision, whether contained in a company’s articles of association or any contract or otherwise, that purports to exempt a director of a company, to any extent, from any liability that would otherwise attach to him or her in connection with any negligence, default, breach of duty or breach of trust in relation to the company, is void. Any provision by which a company directly or indirectly provides an indemnity, to any extent, for a director of the company or of an associated company against any liability attaching to him or her in connection with any negligence, default, breach of duty or breach of trust in relation to the company of which he or she is a director is also void except as permitted by the Companies Act, which provides exceptions for the company to: (i) purchase and maintain insurance against such liability; (ii) provide a “qualifying third-party indemnity,” or an indemnity against liability incurred by the director to a person other than the company or an associated company or criminal proceedings in which he is convicted; and (iii) provide a “qualifying pension scheme indemnity,” or an indemnity against liability incurred in connection with the company’s activities as trustee of an occupational pension plan. | Under Delaware law, a corporation’s certificate of incorporation may include a provision eliminating or limiting the personal liability of a director to the corporation and its stockholders for damages arising from a breach of fiduciary duty as a director. However, no provision can limit the liability of a director for: •any breach of the director’s duty of loyalty to the corporation or its stockholders; •acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law; • intentional or negligent payment of unlawful dividends or stock purchases or redemptions; or •any transaction from which the director derives an improper personal benefit. | ||
Voting Rights | Under English law, unless a poll is demanded by the shareholders of a company or is required by the chairman of the meeting or the company’s articles of association, shareholders shall vote on all resolutions on a show of hands. Under the Companies Act, a poll may be demanded by: (i) not fewer than five shareholders having the right to vote on the resolution; (ii) any shareholder(s) representing not less than 10% of the total voting rights of all the shareholders having the right to vote on the resolution (excluding any voting rights attaching to treasury shares); or (iii) any shareholder(s) holding shares in the company conferring a right to vote on the resolution (excluding any voting rights attaching to treasury shares) being shares on which an aggregate sum has been paid-up equal to not less than 10% of the total sum paid-up on all the shares conferring that right. A company’s articles of association may provide more extensive rights for shareholders to call a poll. Under English law, an ordinary resolution is passed on a show of hands if it is approved by a simple majority (more than 50%) of the votes cast by shareholders present (in person or by proxy) and entitled to vote. If a poll is demanded, an ordinary resolution is passed if it is approved by holders representing a simple majority of the total voting rights of shareholders present, in person or by proxy, who, being entitled to vote, vote on the resolution. Special resolutions require the affirmative vote of not less than 75% of the votes cast by shareholders present, in person or by proxy, at the meeting. | Delaware law provides that, unless otherwise provided in the certificate of incorporation, each stockholder is entitled to one vote for each share of capital stock held by such stockholder. |
Shareholder Vote on Certain Transactions | The Companies Act provides for schemes of arrangement, which are arrangements or compromises between a company and any class of shareholders or creditors and used in certain types of reconstructions, amalgamations, capital reorganizations or takeovers. These arrangements require: • the approval at a shareholders’ or creditors’ meeting convened by order of the court, of a majority in number of shareholders or creditors representing 75% in value of the capital held by, or debt owed to, the class of shareholders or creditors, respectively, present and voting, either in person or by proxy; and •the approval of the court. | Generally, under Delaware law, unless the certificate of incorporation provides for the vote of a larger portion of the stock, completion of a merger, consolidation, sale, lease or exchange of all or substantially all of a corporation’s assets or dissolution requires: •the approval of the board of directors; and •the approval by the vote of the holders of a majority of the outstanding stock or, if the certificate of incorporation provides for more or less than one vote per share, a majority of the votes of the outstanding stock of the corporation entitled to vote on the matter. |
Standard of Conduct for Directors | Under English law, a director owes various statutory and fiduciary duties to the company, including: • to act in the way he considers, in good faith, would be most likely to promote the success of the company for the benefit of its members as a whole; •to avoid a situation in which he has, or can have, a direct or indirect interest that conflicts, or possibly conflicts, with the interests of the company; • to act in accordance with the company’s constitution and only exercise his or her powers for the purposes for which they are conferred; •to exercise independent judgment; •to exercise reasonable care, skill and diligence; •not to accept benefits from a third party conferred by reason of his or her being a director or doing, or not doing, anything as a director; and •to declare any interest that he has, whether directly or indirectly, in a proposed or existing transaction or arrangement with the company. | Delaware law does not contain specific provisions setting forth the standard of conduct of a director. The scope of the fiduciary duties of directors is generally determined by the courts of the State of Delaware. In general, directors have a duty to act without self-interest, on a well- informed basis and in a manner they reasonably believe to be in the best interests of the stockholders. Directors of a Delaware corporation owe fiduciary duties of care and loyalty to the corporation and to its stockholders. The duty of care generally requires that a director acts in good faith, with the care that an ordinarily prudent person would exercise under similar circumstances. Under this duty, a director must inform himself of all material information reasonably available regarding a significant transaction. The duty of loyalty requires that a director act in a manner he reasonably believes to be in the best interests of the corporation. They must not use their corporate position for personal gain or advantage. In general, but subject to certain exceptions, actions of a director are presumed to have been made on an informed basis, in good faith and in the honest belief that the action taken was in the best interests of the corporation. However, this presumption may be rebutted by evidence of a breach of one of the fiduciary duties. Delaware courts have also imposed a heightened standard of conduct upon directors of a Delaware corporation who take any action designed to defeat a threatened change in control of the corporation. In addition, under Delaware law, when the board of directors of a Delaware corporation approves the sale or breakup of a corporation, the board of directors may, in certain circumstances, have a duty to obtain the highest value reasonably available to the shareholders. | ||
Shareholder Litigation | Under English law, generally, the company, rather than its shareholders, is the proper claimant in an action in respect of a wrong done to the company or where there is an irregularity in the company’s internal management. Notwithstanding this general position, the Companies Act provides that (i) a court may allow a shareholder to bring a derivative claim (that is, an action in respect of and on behalf of the company) in respect of a cause of action arising from a director’s negligence, default, breach of duty or breach of trust and (ii) a shareholder may bring a claim for a court order where the company’s affairs have been or are being conducted in a manner that is unfairly prejudicial to some or all of its shareholders. | Under Delaware law, a stockholder may initiate a derivative action to enforce a right of a corporation if the corporation fails to enforce the right itself. The complaint must: •state that the plaintiff was a stockholder at the time of the transaction of which the plaintiff complains or that the plaintiff’s shares thereafter devolved on the plaintiff by operation of law; and •allege with particularity the efforts made by the plaintiff to obtain the action the plaintiff desires from the directors and the reasons for the plaintiff’s failure to obtain the action; or •state the reasons for not making the effort. Additionally, the plaintiff must remain a stockholder through the duration of the derivative suit. The action will not be dismissed or compromised without the approval of the Delaware Court of Chancery. |
(in $ million) | SEK | EUR | GBP | |||
(Increase)/decrease in operating income (loss) ........................................ | $(76) | $46 | $2 |
Amounts in USD millions | 2025 | 2024 | ||
Audit fee | 7.6 | 9.1 | ||
Audit related fee | 2.4 | 0.7 | ||
Tax fee | — | — | ||
All other fees | — | — | ||
Total | $10.0 | $9.8 |
NYSE Domestic Issuer Standard (Selected) | Klarna Group plc Practice / Home-Country Practice |
Compensation Committee (NYSE 303A.05) | The Company has a combined Remuneration and Nomination Committee governed by a written charter and composed entirely of independent directors. The committee discharges responsibilities typically allocated to separate NYSE domestic issuer compensation and nominating/corporate governance committees, including executive remuneration policy and determinations and Board/committee composition, nomination and succession planning. |
Nominating/Corporate Governance Committee (NYSE 303A.04) | The Company addresses nomination and governance matters through the combined Remuneration and Nomination Committee (rather than a separate committee). The committee is composed entirely of independent directors and operates under a written charter. |
Shareholder Approval of Equity Compensation plans (NYSE Listed Company Manual §303A.08) | Under NYSE rules applicable to U.S. domestic issuers, shareholder approval is generally required for equity compensation plans and material amendments thereto. Under English law and the Company’s articles of association, shareholder approval of equity compensation plans or grants thereunder is not required in all circumstances, provided that shareholders have approved sufficient authority to allot shares and to disapply pre-emption rights. While shareholders may be required to vote on the Company’s remuneration policy and remuneration report in accordance with English law, such votes do not constitute plan-specific shareholder approval of equity compensation arrangements. Klarna follows its English home-country practice in this regard. |
Exhibit No. | Description | Schedule/ Form | File Number | Exhibit | File Date | |
2.1** | Description of Securities | |||||
3.1* | Articles of Association | |||||
4.1* | Form of Ordinary Share Certificate | Form F-1/ A | 333-285826 | 4.1 | September 2, 2025 | |
4.2* | Terms and Conditions of Senior Unsecured Notes due 2026, issued by Klarna Bank AB on March 21, 2024, Senior Unsecured Notes due 2026, issued by Klarna Bank AB on June 24, 2024, and Senior Unsecured Notes due 2027, issued by Klarna Bank AB on June 24, 2024 | Form F-1/ A | 333-285826 | 4.2 | September 2, 2025 | |
4.3* | Final Terms of Senior Unsecured Notes due 2026, issued by Klarna Bank AB on March 21, 2024 | Form F-1/ A | 333-285826 | 4.3 | September 2, 2025 | |
4.4* | Final Terms of Senior Unsecured Notes due 2026, issued by Klarna Bank AB on June 24, 2024 | Form F-1/ A | 333-285826 | 4.4 | September 2, 2025 | |
4.5* | Final Terms of Senior Unsecured Notes due 2027, issued by Klarna Bank AB on June 24, 2024 | Form F-1/ A | 333-285826 | 4.5 | September 2, 2025 | |
4.6* | Terms and Conditions of Tier 2 Subordinated Notes due 2033, issued by Klarna Holding AB on May 16, 2023 | Form F-1/ A | 333-285826 | 4.6 | September 2, 2025 | |
4.7* | Terms and Conditions of Tier 2 Subordinated Notes due 2033, issued by Klarna Holding AB on August 16, 2023 | Form F-1/ A | 333-285826 | 4.7 | September 2, 2025 | |
4.8* | Terms and Conditions of Tier 2 Subordinated Notes due 2034, issued by Klarna Holding AB on April 19, 2024 | Form F-1/ A | 333-285826 | 4.8 | September 2, 2025 | |
4.9* | Pricing Supplement of Tier 2 Subordinated Notes due 2034, issued by Klarna Holding AB on April 19, 2024 | Form F-1/ A | 333-285826 | 4.9 | September 2, 2025 | |
4.10* | Terms and Conditions of perpetual Additional Tier 1 Capital Notes, issued by Klarna Bank AB on March 25, 2022, as amended and restated on April 4, 2024 | Form F-1/ A | 333-285826 | 4.10 | September 2, 2025 | |
4.11* | Terms and Conditions of perpetual Additional Tier 1 Capital Notes, issued by Klarna Holding AB on February 1, 2024 | Form F-1/ A | 333-285826 | 4.11 | September 2, 2025 | |
4.12* | Final Terms of Senior Preferred Floating Rate Notes due 2027, issued by Klarna Bank AB on June 11, 2025 | Form F-1/ A | 333-285826 | 4.12 | September 2, 2025 | |
4.13* | Final Terms of Senior Preferred Floating Rate Notes due 2028, issued by Klarna Bank AB on June 11, 2025 | Form F-1/ A | 333-285826 | 4.13 | September 2, 2025 | |
8.1* | List of Subsidiaries of the registrant | |||||
10.1+* | Form of Option Agreement between Klarna Group plc and certain executive officers | Form F-1/ A | 333-285826 | 10.1 | September 2, 2025 | |
10.2+* | Form of Warrant Agreement (Series L[x]) between Klarna Bank AB and certain executive officers | Form F-1/ A | 333-285826 | 10.2 | September 2, 2025 | |
10.3+* | Form of Terms and Conditions for Warrants | Form F-1/ A | 333-285826 | 10.3 | September 2, 2025 | |
10.4+* | Form of Fixed Equity Option Agreement between Klarna Group plc and certain executive officers | Form F-1/ A | 333-285826 | 10.4 | September 2, 2025 | |
10.5+* | Omnibus Equity Incentive Plan | Form F-1/ A | 333-285826 | 10.5 | September 2, 2025 | |
10.6†** | Registration Rights Agreement | |||||
10.7* | Form of Indemnification Agreement | Form F-1/ A | 333-285826 | 10.7 | September 2, 2025 | |
10.8+* | Klarna RSU Plan Rules | Form F-1/ A | 333-285826 | 10.8 | September 2, 2025 |
10.9+* | Form of Option Agreement between Klarna Group plc and Sebastian Siemiatkowski with respect to C Shares | Form F-1/ A | 333-285826 | 10.9 | September 2, 2025 | |
10.10+* | Form of Fixed Equity Option Agreement between Klarna Group plc and Sebastian Siemiatkowski with respect to C Shares | Form F-1/ A | 333-285826 | 10.10 | September 2, 2025 | |
11.1** | Insider Trading Policy | |||||
12.1** | Certification of Sebastian Siemiatkowski, Chief Executive Officer of Klarna Group plc, pursuant to Section 302 of Sarbanes-Oxley Act of 2002 | |||||
12.2** | Certification of Niclas Neglén, Chief Financial Officer of Klarna Group plc, pursuant to Section 302 of Sarbanes-Oxley Act of 2002 | |||||
12.3** | Certification of Sebastian Siemiatkowski, Chief Executive Officer of Klarna Group plc, pursuant to pursuant to Section 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |||||
12.4** | Certification of Niclas Neglén, Chief Financial Officer of Klarna Group plc, pursuant to pursuant to Section 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |||||
23.1** | Consent of Ernst & Young AB | |||||
97.1** | Compensation Recoupment Policy |
KLARNA GROUP PLC | ||
Date: February 26, 2026 | By: | /s/ Sebastian Siemiatkowski |
Name: Sebastian Siemiatkowski | ||
Title: Chief Executive Officer | ||
Date: February 26, 2026 | By: | /s/ Niclas Neglén |
Name: Niclas Neglén | ||
Title: Chief Financial Officer | ||
Report of Independent Registered Public Accounting Firm (Firm ID - | F-2 |
Consolidated Statements of Profit or Loss for the Years Ended December 31, 2025, 2024 and 2023 ......................................................................................................................................................... | F-4 |
Consolidated Statements of Comprehensive Loss for the Years Ended December 31, 2025, 2024 and 2023 ............................................................................................................................................... | F-5 |
Consolidated Balance Sheets for the Years Ended December 31, 2025 and 2024 ...................... | F-6 |
Consolidated Statements of Shareholders’ Equity for the Years Ended December 31, 2025, 2024 and 2023 ............................................................................................................................................... | F-7 |
Consolidated Statements of Cash Flows for the Years Ended December 31, 2025, 2024 and 2023 ................................................................................................................................................................. | F-8 |
Notes to consolidated financial statements ........................................................................................... | F-9 |
Description of the Matter ................. | As described in Notes 2 and 6 to the consolidated financial statements, the Company recorded consumer receivables of $10,459 million net of allowances for expected credit losses of $492 million. Allowances for expected credit losses (“ECL”) are based on the individual loan’s estimated repayment performance and the evaluation of accumulated credit risk by product, geography, and days past due. The probability of default, magnitude of estimated loss, and expected changes in exposure are derived from historical internal and external data. Auditing the Company’s allowance for ECL was complex due to the estimation uncertainty in loan repayment performance, accumulated credit risk assumptions, the highly automated nature of the Company’s consumer receivable process, and the complexity of the models and assumptions used to calculate ECL. | |
How We Addressed the Matter in Our Audit .............................................. | To test the Company’s allowance for ECL our audit procedures included, among others, testing inputs and assumptions noted above used in management’s model calculations including but not limited to, days past due, historical loan repayment performance and probability of default. With the support of our internal specialists, we performed procedures on certain models used to determine the allowance for ECL, including, new model implementation testing, assessment of model performance, and sensitivity analyses. We evaluated the Company’s validation procedures over a sample of models and assessed the potential impact of future economic conditions and the application of historical internal and external data by comparing realized losses to previous estimates made by management. |
Description of the Matter ................. | As described in Notes 2 and 4 to the consolidated financial statements, merchant revenue primarily refers to merchant fees, which are derived from the volume of consumer transactions processed and a combination of value-based and fixed pricing. The transaction price is recognized at the point in time when the merchant successfully confirms the transaction, which is when the terms of the contract are fulfilled. A reduction of merchant fees to certain merchants is provided based on performance measures, including volume of processed transactions. Auditing merchant fees was complex due to the judgment required to assess management’s accounting for key terms and conditions within certain merchant contracts. | |
How We Addressed the Matter in Our Audit .............................................. | Our audit procedures to test the Company’s merchant fees included among others, on a sample basis, reviewing and evaluating merchant contracts, including those with performance measures. We tested transactions with value- based and fixed pricing terms and recalculated merchant fees by comparing rates within contracts to transaction data. We tested occurrence and evaluated completeness by reviewing consumer transaction evidence and comparing merchant fee amounts to subsequent cash settlements. |
Amounts in USD millions, except share and per share amounts | Note | 2025 | 2024 | 2023 | ||||
Transaction and service revenue .............................................. | ||||||||
Gain on sale of consumer receivables ...................................... | ||||||||
Interest income .............................................................................. | ||||||||
Total revenue .................................................................................. | 4 | |||||||
Processing and servicing costs .................................................. | ( | ( | ( | |||||
Provision for credit losses ........................................................... | ( | ( | ( | |||||
Funding costs ................................................................................. | 17 | ( | ( | ( | ||||
Technology and product development .................................... | ( | ( | ( | |||||
Sales and marketing ...................................................................... | ( | ( | ( | |||||
Customer service and operations .............................................. | ( | ( | ( | |||||
General and administrative ......................................................... | ( | ( | ( | |||||
Depreciation, amortization and impairments .......................... | ( | ( | ( | |||||
Operating expenses ........................................................................ | ( | ( | ( | |||||
Operating loss .................................................................................. | ( | ( | ( | |||||
Other income (expense) ............................................................... | ( | |||||||
Profit (loss) before taxes ............................................................... | ( | ( | ||||||
Tax (expense) benefit ................................................................... | ( | ( | ||||||
Net profit (loss) ............................................................................... | ( | ( | ||||||
Whereof attributable to: | ||||||||
Shareholders of Klarna Group plc .............................................. | ( | ( | ||||||
Non-controlling interests ............................................................. | ||||||||
Other equity holders ..................................................................... | ||||||||
Total .................................................................................................. | ( | ( | ||||||
Net profit (loss) per share attributable to shareholders of Klarna Group plc | ||||||||
Basic ................................................................................................. | 25 | $( | $ | $( | ||||
Diluted | 25 | $( | $ | $( |
Amounts in USD millions, except share and per share amounts | 2025 | 2024 | 2023 | |||
Net profit (loss) ................................................................................................... | ( | ( | ||||
Items that are or may be reclassified to the statement of profit or loss: | ||||||
Foreign currency translation differences ................................................... | ||||||
Exchange differences on translation of foreign operations ................ | ( | |||||
Reclassification of cumulative translation adjustments ....................... | ( | |||||
Consumer receivables at fair value through OCI ....................................... | ||||||
Net changes in fair value for the year ....................................................... | ||||||
Changes in expected credit losses ............................................................ | ||||||
Reclassification to the statement of profit and loss ............................. | ( | |||||
Other comprehensive income (loss) for the year .......................................... | ( | |||||
Total comprehensive income (loss) ................................................................. | ( | ( | ||||
Comprehensive income (loss) attributable to: | ||||||
Shareholders of Klarna Group plc ................................................................. | ( | ( | ||||
Non-controlling interests ................................................................................ | ||||||
Other equity holders ........................................................................................ | ||||||
Total comprehensive income (loss) ................................................................. | ( | ( |
Amounts in USD millions, except share and per share amounts | Note | December 31, 2025 | December 31, 2024 | |||
Assets | ||||||
Cash and cash equivalents ........................................................................................ | 5 | |||||
Debt securities .............................................................................................................. | 8 | |||||
Consumer receivables ................................................................................................ | 6 | |||||
Consumer receivables at fair value through OCI .................................................. | 20 | |||||
Consumer receivables at fair value through profit and loss .............................. | 20 | |||||
Settlement and trade receivables ............................................................................ | 7 | |||||
Property and equipment ............................................................................................ | 12 | |||||
Goodwill .......................................................................................................................... | 11 | |||||
Intangible assets .......................................................................................................... | 11 | |||||
Deferred tax assets ..................................................................................................... | 24 | |||||
Other assets .................................................................................................................. | 13 | |||||
Total Assets ................................................................................................................... | ||||||
Liabilities | ||||||
Accounts payable and accrued expenses ............................................................. | ||||||
Consumer deposits ...................................................................................................... | ||||||
Payables to merchants ............................................................................................... | ||||||
Notes payable and other borrowings ...................................................................... | 14 | |||||
Deferred tax liabilities ................................................................................................. | 24 | |||||
Other liabilities .............................................................................................................. | 15 | |||||
Total Liabilities .............................................................................................................. | ||||||
Equity | ||||||
Share capital ................................................................................................................. | 21 | |||||
Additional paid in capital ............................................................................................ | ||||||
Other equity instruments ........................................................................................... | ||||||
Reserves ........................................................................................................................ | ( | ( | ||||
Retained Earnings (Accumulated deficit) ............................................................... | ( | |||||
Total equity excluding non-controlling interests ..................................................... | ||||||
Non-controlling interests ............................................................................................ | ||||||
Total equity .................................................................................................................... | ||||||
Total equity and liabilities ............................................................................................ |
Amounts in USD millions, except share and per share amounts | Share capital | Additional paid in capital | Reserves | Other equity instruments1 | Retained earnings | Equity excluding non-controlling interests | Non-controlling interests1 | Total equity |
Balance as of January 1, 2023 | ( | ( | ||||||
Net loss | — | — | — | — | ( | ( | — | ( |
Exchange differences on translating foreign currencies | — | — | — | — | — | |||
New share issue | — | — | — | — | — | |||
Share-based payments | — | — | — | — | ||||
Redemption of other equity instruments | — | — | — | ( | ( | ( | — | ( |
Changes in non-controlling interests | — | — | — | — | ( | ( | ( | ( |
Balance as of December 31, 2023 | ( | ( | ||||||
Net loss | — | — | — | — | — | |||
Exchange differences on translating foreign currencies | — | — | ( | — | — | ( | ( | ( |
Reclassification | — | — | ( | — | — | ( | — | ( |
New share issue | — | — | — | — | — | |||
Share-based payments | — | — | — | — | — | |||
Issuance of other equity instruments | — | — | — | ( | ( | |||
Changes in non-controlling interests | — | — | — | ( | ( | ( | ( | |
Balance as of December 31, 2024 | ( | ( | ||||||
Net loss | — | — | — | — | ( | ( | ( | |
Exchange differences on translating foreign currencies | — | — | — | — | ( | |||
Consumer Receivables Fair Value through OCI | ||||||||
Share capital reduction2 | — | ( | — | — | ( | — | ( | |
New share issue | — | — | — | ( | — | |||
Share-based payments | — | — | — | — | — | |||
Tax effects on share based payments | — | — | — | ( | ( | ( | ||
Other equity instruments coupons paid | — | — | — | — | ( | |||
Changes in non-controlling interests | — | — | ( | — | ( | ( | ||
Balance as of December 30, 2025 | ( |
2025 | 2024 | 2023 | ||||
Operating activities | ||||||
Profit (loss) before taxes ............................................................................................................ | ( | ( | ||||
Income taxes paid ....................................................................................................................... | ( | ( | ( | |||
Interest expense paid ................................................................................................................ | ( | ( | ( | |||
Interest income received .......................................................................................................... | ||||||
Adjustments for non-cash items in operating activities | ||||||
Depreciation, amortization and impairment ......................................................................... | ||||||
Share-based payments .............................................................................................................. | ||||||
Provisions excluding credit losses .......................................................................................... | ||||||
Provision for credit losses ......................................................................................................... | ||||||
Net gain from divestment1 ........................................................................................................ | ( | |||||
Net losses from divestment of shares in equity investments .......................................... | ||||||
Financial items including fair value effects ........................................................................... | ( | ( | ||||
Changes in the assets and liabilities of operating activities | ||||||
Change in consumer receivables at fair value through OCI .............................................. | ( | |||||
Change in consumer receivable at FV through P&L ........................................................... | ( | ( | ||||
Change in consumer receivables ............................................................................................ | ( | ( | ( | |||
Change in settlement and trade receivables ........................................................................ | ( | ( | ||||
Change in notes payable and other borrowings .................................................................. | ( | ( | ( | |||
Change in consumer deposits .................................................................................................. | ||||||
Change in bonds and treasury bills with maturity > 90 days ............................................. | ( | |||||
Change in other assets and liabilities ..................................................................................... | ( | ( | ||||
Cash flow from operating activities ............................................................................................ | ( | |||||
Investing activities | ||||||
Investments in intangible assets .............................................................................................. | ( | ( | ( | |||
Investments in property and equipment ................................................................................ | ( | ( | ( | |||
Sale of fixed assets ..................................................................................................................... | ||||||
Divestment, net of cash disposed | ||||||
Net purchase of equity investments | ||||||
Cash flow from investing activities ............................................................................................. | ( | ( | ||||
Financing activities | ||||||
New share issuance .................................................................................................................... | ||||||
Share warrants ............................................................................................................................. | ||||||
Other equity instruments issued ............................................................................................. | ||||||
Other equity instruments redeemed ...................................................................................... | ( | |||||
Convertible promissory notes redeemed ............................................................................. | ( | |||||
Subordinated debt issued ........................................................................................................ | ||||||
Subordinated debt redeemed ................................................................................................. | ( | |||||
Notes payable and other borrowings issued ....................................................................... | ||||||
Notes payable and other borrowings redeemed ................................................................ | ( | ( | ( | |||
Principal payments of lease liabilities .................................................................................... | ( | ( | ( | |||
Cash flow from financing activities ............................................................................................. | ( | |||||
Cash flow for the year ................................................................................................................... | ( | |||||
Cash and cash equivalents at the beginning of the year ........................................................ | ||||||
Cash flow for the year ................................................................................................................ | ( | |||||
Exchange rate difference in cash and cash equivalents ................................................... | ( | |||||
Cash and cash equivalents at the end of the year ................................................................... |
Equipment, tools and fixtures and fittings ............................... | ||
Computers and other machinery .............................................. | ||
Leasehold improvements............................................................ | The shorter of lease term and useful life |
2025 | 2024 | 2023 | ||||
Salaries and other remuneration .................................................................. | $( | $( | $( | |||
Statutory and contractual social security expenses ................................ | ( | ( | ( | |||
of which: pension expenses ........................................................................... | ( | ( | ( | |||
Total employee benefits .................................................................................... | $( | $( | $( |
December 31, 2025 | EUR | USD | GBP | Other | Total Exposure | |||||
Net average currency exposure ................... | ||||||||||
Effect of 10% change ...................................... | ( | ( | ( | ( | ( |
December 31, 2024 | EUR | USD | GBP | Other | Total Exposure | |||||
Net average currency exposure ................... | ||||||||||
Effect of 10% change ...................................... | ( | ( | ( | ( | ( |
December 31, 2023 | EUR | USD | GBP | Other | Total Exposure | |||||
Net average currency exposure ................... | ||||||||||
Effect of 10% change ...................................... | ( | ( | ( | ( |
December 31, 2025 | SEK | EUR | USD | GBP | Other | Total Exposure | ||||||
- rates ...................................................... | ( | ( | ||||||||||
rates ...................................................... | ( | ( | ( | ( |
December 31, 2024 | SEK | EUR | USD | GBP | Other | Total Exposure | ||||||
- rates ...................................................... | ( | ( | ||||||||||
rates ...................................................... | ( | ( | ( | ( |
December 31, 2023 | SEK | EUR | USD | GBP | Other | Total Exposure | ||||||
- rates ...................................................... | ( | ( | ||||||||||
rates ...................................................... | ( | ( | ( |
December 31, 2025 | <12 months | 1-5 years | >5 years | Total | ||||
Consumer deposits ............................................................ | $ | $ | $ | $ | ||||
Notes payable and other borrowings ............................. | $ | |||||||
Lease liabilities ................................................................... | ||||||||
Total ...................................................................................... | $ | $ | $ | $ |
December 31, 2024 | <12 months | 1-5 years | >5 years | Total | ||||
Consumer deposits ............................................................ | $ | $ | $ | $ | ||||
Notes payable and other borrowings ............................. | ||||||||
Lease liabilities ................................................................... | ||||||||
Total ....................................................................................... | $ | $ | $ | $ |
2025 | 2024 | 2023 | ||||
Geographical breakdown | ||||||
United States ..................................................................................................... | $ | $ | $ | |||
Germany ............................................................................................................. | ||||||
United Kingdom ................................................................................................. | ||||||
Other countries ................................................................................................. | ||||||
Revenue ............................................................................................................... | $ | $ | $ |
2025 | 2024 | 2023 | ||||
Transaction revenue ........................................................................................ | $ | $ | $ | |||
Consumer service revenue ............................................................................ | ||||||
Gain on sale of consumer receivables ......................................................... | ||||||
Interest income ................................................................................................. | ||||||
Revenue .............................................................................................................. | $ | $ | $ |
Interest income | 2025 | 2024 | 2023 | |||
Fair Financing .................................................................................................... | $ | $ | $ | |||
"Snooze" fees .................................................................................................... | ||||||
Debt securities .................................................................................................. | ||||||
Incremental merchant fees ............................................................................ | ||||||
Interest income .................................................................................................. | $ | $ | $ |
December 31, 2025 | December 31, 2024 | December 31, 2023 | ||||
Non-current assets | ||||||
Sweden ............................................................................................................... | $ | $ | $ | |||
Germany ............................................................................................................. | ||||||
United States ..................................................................................................... | ||||||
United Kingdom ................................................................................................. | ||||||
Other countries ................................................................................................. | ||||||
Total non-current assets ................................................................................... | $ | $ | $ |
December 31, 2025 | December 31, 2024 | |||
Cash held at central banks ........................................................................................................... | $ | $ | ||
Treasury bills held at central banks ............................................................................................ | ||||
Other bank deposits ....................................................................................................................... | ||||
Total cash and cash equivalents .................................................................................................... | $ | $ |
December 31, 2025 | ||||||
Gross Carrying Amount | Allowance for ECL | Net Carrying Amount | ||||
Fair Financing receivables .............................................................................. | $ | $( | $ | |||
Pay Later receivables ...................................................................................... | ( | |||||
Total ..................................................................................................................... | $ | $( | $ | |||
December 31, 2024 | ||||||
Gross Carrying Amount | Allowance for ECL | Net Carrying Amount | ||||
Fair Financing receivables ........................................................................ | $ | $( | $ | |||
Pay Later receivables ................................................................................ | ( | |||||
Total ............................................................................................................... | $ | $( | $ | |||
Fair Financing receivables | Stage 1 | Stage 2 | Stage 3 | Total | ||||
Gross carrying amount as of January 1, 2025 .................. | $ | $ | $ | $ | ||||
New assets originated or purchased ............................. | ||||||||
Assets repaid1...................................................................... | ( | ( | ( | ( | ||||
Transfers to stage 1 ............................................................ | ( | ( | ||||||
Transfers to stage 2 ........................................................... | ( | ( | ||||||
Transfers to stage 3 ........................................................... | ( | ( | ||||||
Amounts written off ........................................................... | ( | ( | ( | ( | ||||
Proceeds received from the sale of uncollectible consumer receivables ....................................................... | ( | ( | ( | ( | ||||
Other adjustments2 ............................................................ | ||||||||
Gross carrying amount as of December 31, 2025 ............ | $ | $ | $ | $ |
Pay Later receivables | Stage 1 | Stage 2 | Stage 3 | Total | ||||
Gross carrying amount as of January 1, 2025 .................. | $ | $ | $ | $ | ||||
New assets originated or purchased ............................. | ||||||||
Assets repaid ...................................................................... | ( | ( | ( | ( | ||||
Transfers to stage 1 ............................................................ | ( | ( | ||||||
Transfers to stage 2 ........................................................... | ( | ( | ||||||
Transfers to stage 3 ........................................................... | ( | ( | ||||||
Amounts written off ........................................................... | ( | ( | ( | ( | ||||
Proceeds received from the sale of uncollectible consumer receivables ....................................................... | ( | ( | ||||||
Other adjustments1 ............................................................ | ||||||||
Gross carrying amount as of December 31, 2025 ............ | $ | $ | $ | $ |
Stage 1 | Stage 2 | Stage 3 | Total | |||||
Gross carrying amount as of January 1, 2024 .................. | $ | $ | $ | $ | ||||
New assets originated or purchased ............................. | ||||||||
Assets repaid ...................................................................... | ( | ( | ( | ( | ||||
Transfers to stage 1 ............................................................ | ( | ( | ||||||
Transfers to stage 2 ........................................................... | ( | ( | ||||||
Transfers to stage 3 ........................................................... | ( | ( | ||||||
Amounts written off ........................................................... | ( | ( | ( | ( | ||||
Proceeds received from the sale of consumer receivables .......................................................................... | ( | ( | ( | |||||
Other adjustments ............................................................. | ( | ( | ( | ( | ||||
Gross carrying amount as of December 31, 2024 ........... | $ | $ | $ | $ |
Fair Financing receivables | Stage 1 | Stage 2 | Stage 3 | Total | ||||
Allowance as of January 1, 2025 ....................................... | $( | $( | $( | $( | ||||
New assets originated or purchased ............................. | ( | ( | ( | ( | ||||
Assets repaid ...................................................................... | ||||||||
Transfers to stage 1 ............................................................ | ( | |||||||
Transfers to stage 2 ........................................................... | ( | |||||||
Transfers to stage 3 ........................................................... | ( | |||||||
Other movements in ECL allowance .............................. | ( | ( | ( | ( | ||||
Amounts written off ........................................................... | ||||||||
Other adjustments1 ............................................................ | ( | |||||||
Allowance as of December 31, 2025 ................................. | $( | $( | $( | $( |
Pay Later receivables | Stage 1 | Stage 2 | Stage 3 | Total | ||||
Allowance as of January 1, 2025 ....................................... | $( | $( | $( | $( | ||||
New assets originated or purchased ............................. | ( | ( | ( | ( | ||||
Assets repaid ...................................................................... | ||||||||
Transfers to stage 1 ............................................................ | ( | |||||||
Transfers to stage 2 ........................................................... | ( | |||||||
Transfers to stage 3 ........................................................... | ( | |||||||
Other movements in ECL allowance .............................. | ( | ( | ( | ( | ||||
Amounts written off ........................................................... | ||||||||
Other adjustments1 ............................................................ | ( | ( | ( | ( | ||||
Allowance as of December 31, 2025 ................................. | $( | $( | $( | $( |
Stage 1 | Stage 2 | Stage 3 | Total | |||||
Allowance as of January 1, 2024 ....................................... | $( | $( | $( | $( | ||||
New assets originated or purchased ............................. | ( | ( | ( | ( | ||||
Assets repaid ...................................................................... | ||||||||
Transfers to stage 1 ............................................................ | ( | |||||||
Transfers to stage 2 ........................................................... | ( | |||||||
Transfers to stage 3 ........................................................... | ( | |||||||
Impact on ECL from change in credit risk .................... | ( | ( | ( | ( | ||||
Amounts written off ........................................................... | ||||||||
Other adjustments ............................................................. | ( | ( | ||||||
Allowance as of December 31, 2024 ................................. | $( | $( | $( | $( |
December 31, 2025 | |||||
Gross Carrying Amount | Allowance for ECL | Net Carrying Amount | |||
Payment service providers receivables | ( | ||||
Merchant receivables | ( | ||||
Debt collection receivables | |||||
Other receivables | |||||
Total | ( | ||||
December 31, 2024 | |||||
Gross Carrying Amount | Allowance for ECL | Net Carrying Amount | |||
Payment service providers receivables ........................................................ | $ | $ | - 1 | $ | |
Merchant receivables ....................................................................................... | ( | - 2 5 | |||
Debt collection receivables ............................................................................. | 0 | ||||
Other receivables ............................................................................................... | 0 | ||||
Total ..................................................................................................................... | $ | $( | $ | ||
December 31, 2025 | December 31, 2024 | |||
Treasury bills chargeable at central banks ............................................................................... | $ | $ | ||
Mandatory deposits at central banks ......................................................................................... | ||||
Bonds and other interest bearing securities ............................................................................ | ||||
Total ................................................................................................................................................... | $ | $ |
2025 | 2024 | 2023 | ||||
Depreciation of right-of-use assets .............................................................. | ( | ( | ( | |||
Impairments of right-of-use assets ............................................................... | ( | ( | ( | |||
Interest expense for lease liabilities ............................................................. | ( | ( | ( | |||
Total right-of-use lease cost ............................................................................. | ( | ( | ( | |||
Expenses relating to short-term leases ....................................................... | ( | ( | ( | |||
Total short-term and low-value leases ............................................................ | ( | ( | ( |
October 1, 2024 | ||
Consideration received or receivable: ...................................................................................................................... | ||
Cash ............................................................................................................................................................................... | $ | |
Fair value of contingent consideration ................................................................................................................... | ||
Less: transaction costs .............................................................................................................................................. | ( | |
Total disposal consideration ...................................................................................................................................... | ||
Carrying amount of net assets sold ......................................................................................................................... | ( | |
Gain on sale before income tax and reclassification of foreign currency translation reserve .......................... | ||
Gain on sale after income tax ..................................................................................................................................... | $ |
Goodwill | Trademarks, Tradenames & Licenses | Capitalized development expenses | Other intangible assets | Total | ||||||
Cost as of January 1, 2025 ............................... | $ | $ | $ | $ | $ | |||||
Additions ........................................................... | — | |||||||||
Sales/disposals ............................................... | ||||||||||
Currency translation difference .................. | ||||||||||
Cost as of December 31, 2025 ......................... | $ | $ | $ | $ | $ | |||||
Amortization as of January 1, 2025 ................ | $ | $( | $( | $( | $( | |||||
Amortization for the year .............................. | — | ( | ( | ( | ( | |||||
Sales/disposals ............................................... | ||||||||||
Currency translation difference .................. | ( | ( | ( | ( | ||||||
Amortization as of December 31, 2025 .......... | $ | $( | $( | $( | $( | |||||
Impairment as of January 1, 2025 ................... | $( | $( | $( | $( | $( | |||||
Impairment for the year ................................ | ( | ( | ||||||||
Sales/disposals ............................................... | ||||||||||
Currency translation difference .................. | ( | ( | ( | |||||||
Impairment as of December 31, 2025 ............ | $( | $( | $( | $( | $( | |||||
Carrying amount as of December 31, 2025 ... | $ | $ | $ | $ | $ |
Goodwill | Trademarks, Tradenames & Licenses | Capitalized development expenses | Other intangible assets | Total | ||||||
Cost as of January 1, 2024 ................................ | $ | $ | $ | $ | $ | |||||
Additions ............................................................ | — | |||||||||
Sales/disposals ................................................ | ( | ( | ( | ( | ||||||
Currency translation difference ................... | ( | ( | ( | ( | ( | |||||
Cost as of December 31, 2024 ......................... | $ | $ | $ | $ | $ | |||||
Amortization as of January 1, 2024 ................. | $ | $( | $( | $( | $( | |||||
Amortization for the year ............................... | — | ( | ( | ( | ( | |||||
Sales/disposals ................................................ | ||||||||||
Currency translation difference ................... | ||||||||||
Amortization as of December 31, 2024 ........... | $ | $( | $( | $( | $( | |||||
Impairment as of January 1, 2024 ................... | $( | $( | $( | $( | $( | |||||
Impairment for the year ................................. | ( | ( | ( | |||||||
Sales/disposals ................................................ | ||||||||||
Currency translation difference ................... | ||||||||||
Impairment as of December 31, 2024 ............. | $( | $( | $( | $( | $( | |||||
Carrying amount as of December 31, 2024 .... | $ | $ | $ | $ | $ |
Leasehold improvements | Equipment | Right-of-use assets | Total | |||||
Cost value as of January 1, 2025 ........................................ | ||||||||
Additions .............................................................................. | ||||||||
Sales/disposals ................................................................... | ( | ( | ( | |||||
Remeasurement ................................................................. | ( | ( | ||||||
Currency translation difference ...................................... | ||||||||
Cost value as of December 31, 2025 .................................. | ||||||||
Depreciation as of January 1, 2025 ................................... | ( | ( | ( | ( | ||||
Depreciation for the year ................................................. | ( | ( | ( | |||||
Sales/disposals ................................................................... | ||||||||
Currency translation difference ...................................... | ( | ( | ( | ( | ||||
Depreciation as of December 31, 2025.............................. | ( | ( | ( | ( | ||||
Impairment as of January 1, 2025 ...................................... | ( | ( | ( | ( | ||||
Impairment for the year .................................................... | ( | ( | ( | ( | ||||
Sales/disposals ................................................................... | ||||||||
Currency translation difference ...................................... | ( | ( | ( | |||||
Impairment as of December 31, 2025 ................................ | ( | ( | ( | ( | ||||
Carrying amount as of December 31, 2025 ....................... |
Leasehold improvements | Equipment | Right-of-use assets | Total | |||||
Cost value as of January 1, 2024 ......................................... | $ | $ | $ | $ | ||||
Additions ............................................................................... | ||||||||
Sales/disposals ................................................................... | ( | ( | ( | ( | ||||
Remeasurement .................................................................. | ( | ( | ||||||
Currency translation difference ...................................... | ( | ( | ( | ( | ||||
Cost value as of December 31, 2024 .................................. | $ | $ | $ | $ | ||||
Depreciation as of January 1, 2024 .................................... | $( | $( | $( | $( | ||||
Depreciation for the year .................................................. | ( | ( | ( | ( | ||||
Sales/disposals ................................................................... | ||||||||
Currency translation difference ...................................... | ||||||||
Depreciation as of December 31, 2024 .............................. | $( | $( | $( | $( | ||||
Impairment as of January 1, 2024 ...................................... | $( | $( | $( | $( | ||||
Impairment for the year .................................................... | ( | ( | ||||||
Sales/disposals ................................................................... | ||||||||
Currency translation difference ...................................... | ||||||||
Impairment as of December 31, 2024 ................................ | $( | $( | $( | $( | ||||
Carrying amount as of December 31, 2024 ....................... | $ | $ | $ | $ |
December 31, 2025 | December 31, 2024 | |||
Current tax assets ........................................................................................................................... | $ | $ | ||
VAT receivables .............................................................................................................................. | ||||
Commercial agreement assets .................................................................................................... | ||||
Derivatives ........................................................................................................................................ | ||||
Accrued income .............................................................................................................................. | ||||
Prepaid expenses ........................................................................................................................... | ||||
Equity investments ......................................................................................................................... | ||||
Collateral for derivatives ............................................................................................................... | ||||
Securitization partner receivable ................................................................................................ | ||||
Other receivables ............................................................................................................................ | ||||
Total ................................................................................................................................................... | $ | $ |
December 31, 2025 | December 31, 2024 | |||
Liabilities to financial institutions ................................................................................................ | $ | $ | ||
Commercial papers ........................................................................................................................ | ||||
Derivatives ........................................................................................................................................ | ||||
Senior unsecured bonds ............................................................................................................... | ||||
Subordinated liabilities .................................................................................................................. | ||||
Warehouse financing facility ........................................................................................................ | ||||
Total ................................................................................................................................................... | $ | $ |
December 31, 2025 | December 31, 2024 | |||
Lease liabilities ................................................................................................................................ | $ | $ | ||
Commercial agreement liabilities ................................................................................................ | ||||
Income and payroll tax payables ................................................................................................. | ||||
Provisions .......................................................................................................................................... | ||||
Card scheme liabilities ................................................................................................................... | ||||
Payable to SPV1 ............................................................................................................................... | ||||
Other liabilities ................................................................................................................................. | ||||
Total ................................................................................................................................................... | $ | $ |
December 31, 2025 | December 31, 2024 | |||
Consumer receivables at fair value through OCI ..................................................................... | $ | $ | ||
Consumer receivables at fair value through profit and loss ................................................. | ||||
Pledged assets under forward flow arrangements1 ................................................................. | ||||
Total assets ....................................................................................................................................... | $ | $ | ||
Payable to SPV2 ............................................................................................................................... | ||||
Total liabilities ................................................................................................................................... | $ | $ |
2025 | 2024 | 2023 | ||||
Consumer deposits | $( | $( | $( | |||
Fair value adjustment on loans sold and held for sale | ( | ( | ||||
Other cost of securitisations | ( | ( | ( | |||
Interest-bearing securities | ( | ( | ( | |||
Liabilities to credit institutions | ( | ( | ( | |||
Subordinated liabilities | ( | ( | ( | |||
Other funding costs | ( | ( | ( | |||
Total | $( | $( | $( |
December 31, 2025 | ||||||
Fair value | Nominal amount | |||||
Derivatives designated in a hedged relationship | Positive | Negative | ||||
Interest rate swaps ........................................................................................... | $ | $( | $ | |||
Total ..................................................................................................................... | $ | $( | $ | |||
Fair value | Nominal amount | |||||
Derivatives not designated in a hedged relationship | Positive | Negative | ||||
Currency forwards ............................................................................................ | $ | $( | $ | |||
Total ..................................................................................................................... | $ | $( | $ | |||
December 31, 2024 | ||||||
Fair value | Nominal amount | |||||
Derivatives designated in a hedged relationship | Positive | Negative | ||||
Interest rate swaps ........................................................................................... | $ | $( | $ | |||
Total ..................................................................................................................... | $ | $( | $ | |||
Fair value | Nominal amount | |||||
Derivatives not designated in a hedged relationship | Positive | Negative | ||||
Currency forwards ............................................................................................ | $ | $( | $ | |||
Total ..................................................................................................................... | $ | $( | $ | |||
December 31, 2025 | ||||||||||
Carrying amount | Change in fair value used to calculate hedge ineffectiveness | Ineffectiveness recognized in funding costs | ||||||||
Fair value hedges: Hedging instrument and ineffectiveness | Nominal amount | Positive | Negative | |||||||
Interest rate risk ......................... | $ | $ | $( | $( | $ | |||||
Total .............................................. | $ | $ | $( | $( | $ | |||||
December 31, 2024 | ||||||||||
Carrying amount | Change in fair value used to calculate hedge ineffectiveness | Ineffectiveness recognized in funding costs | ||||||||
Fair value hedges: Hedging instrument and ineffectiveness | Nominal amount | Positive | Negative | |||||||
Interest rate risk ......................... | $ | $ | $( | $( | $ | |||||
Total .............................................. | $ | $ | $( | $( | $ | |||||
December 31, 2025 | December 31, 2024 | |||
Fair value hedges: Designated hedged item | ||||
Consumer deposits ..................................................................................................................... | $ | $ | ||
Of which: the accumulated amount of fair value adjustment .......................................... | $( | $ |
Maturity 2025 | Maturity 2024 | ||||||||||
Within 3 months | > 3 months and < 12 months | > 12 months | Within 3 months | > 3 months and < 12 months | > 12 months | ||||||
Fair value hedges: Maturity of the nominal amount of the hedge instrument | |||||||||||
Interest rate risk .............................................. | $ | $ | $ | $ | $ | $ | |||||
Average fixed interest rate ........................... | |||||||||||
December 31, 2025 | December 31, 2024 | |||
Pledged assets | ||||
Assets pledged for own liabilities | ||||
Pledged consumer receivables .................................................................................................... | $ | $ | ||
Pledged treasury bills chargeable at central banks, etc., and pledged bonds and other interest-bearing securities ................................................................................................. | ||||
Other pledged assets ..................................................................................................................... | ||||
Total ................................................................................................................................................... | $ | $ |
December 31, 2025 | December 31, 2024 | |||
Commitments for loan funding .................................................................................................... | $ | $ | ||
Guarantees ....................................................................................................................................... | ||||
Total ................................................................................................................................................... | $ | $ |
December 31, 2025 | ||||||||
Financial Instruments | Level 1 | Level 2 | Level 3 | Total | ||||
Assets | ||||||||
Consumer receivables at fair value through P&L .. | ||||||||
Consumer receivables at fair value through OCI .. | ||||||||
Derivatives ..................................................................... | $ | $ | $ | $ | ||||
Equity investments ....................................................... | ||||||||
Total financial assets ..................................................... | $ | $ | $ | $ | ||||
Liabilities | ||||||||
Derivatives ..................................................................... | $ | $ | $ | $ | ||||
Convertible notes ......................................................... | ||||||||
Total financial liabilities ................................................. | $ | $ | $ | $ | ||||
December 31, 2024 | ||||||||
Financial Instruments | Level 1 | Level 2 | Level 3 | Total | ||||
Assets | ||||||||
Consumer receivables at fair value through OCI .. | $ | $ | $ | $ | ||||
Consumer receivables at fair value through P&L .. | ||||||||
Derivatives ..................................................................... | ||||||||
Equity investments ....................................................... | ||||||||
Total financial assets ..................................................... | $ | $ | $ | $ | ||||
Liabilities | ||||||||
Derivatives ..................................................................... | $ | $ | $ | $ | ||||
Convertible notes ......................................................... | ||||||||
Total financial liabilities ................................................. | $ | $ | $ | $ | ||||
Financial assets | ||||||
Equity investments | Consumer receivables at fair value through P&L | Consumer receivables at fair value through OCI | ||||
Balance as of January 1, 2024 ..................................................................... | $ | $ | $ | |||
Receivables originated to be sold ........................................................... | ||||||
Gain/(loss) in statement of profit or loss (1) .......................................... | ( | ( | ||||
of which: unrealized gain/(loss) ............................................................... | ( | |||||
of which: realized gain/(loss) .................................................................... | ( | |||||
Receivables sold to third parties ............................................................. | ( | |||||
Balance as of December 31, 2024 ............................................................... | $ | $ | $ | |||
Receivables originated to be sold | ||||||
Receivables sold to third parties ............................................................. | ( | ( | ||||
Consumer receivables repaid .................................................................. | ( | |||||
Gain/(loss) in statement of profit or loss1 .............................................. | ( | ( | ||||
of which: unrealized gain/(loss) ............................................................... | ( | |||||
of which: realized gain/(loss) .................................................................... | ( | |||||
Balance as of December 31, 2025 ............................................................... | $ | $ | $ | |||
Financial Instruments | December 31, 2025 | |||||||||
Assets | Carrying Amount | Level 1 | Level 2 | Level 3 | Balance at Fair Value | |||||
Treasury bills chargeable at central banks ................................. | $ | $ | $ | $ | $ | |||||
Bonds and other interest bearing securities ......................... | ||||||||||
Total financial assets ..................... | $ | $ | $ | $ | $ | |||||
Liabilities | ||||||||||
Consumer deposits ....................... | $ | $ | $ | $ | $ | |||||
Subordinated liabilities ................ | ||||||||||
Senior unsecured bonds ............. | ||||||||||
Commercial papers ...................... | ||||||||||
Total financial liabilities ................. | $ | $ | $ | $ | $ | |||||
Financial Instruments | December 31, 2024 | |||||||||
Assets | Carrying Amount | Level 1 | Level 2 | Level 3 | Balance at Fair Value | |||||
Treasury bills chargeable at central banks .................................. | $ | $ | $ | $ | $ | |||||
Bonds and other interest bearing securities .......................... | ||||||||||
Total financial assets ...................... | $ | $ | $ | $ | $ | |||||
Liabilities | ||||||||||
Consumer deposits ........................ | $ | $ | $ | $ | $ | |||||
Subordinated liabilities ................. | ||||||||||
Senior unsecured bonds .............. | ||||||||||
Commercial papers ....................... | ||||||||||
Total financial liabilities .................. | $ | $ | $ | $ | $ | |||||
2025 | 2024 | |||
Financial instruments mandatory measured at fair value through profit or loss ....... | $( | $( | ||
Financial assets measured at amortized cost .................................................................... | $ | |||
Financial liabilities measured at amortized cost ............................................................... | $( | ( | ||
Currency exchange gains/losses .......................................................................................... | $( | |||
Total ............................................................................................................................................. | $ | $ |
Ordinary shares | Class B shares | Class C shares | Deferred shares | Deferred shares | Deferred shares | Deferred shares | |
Nominal value | $ | $ | $ | $ | $ | $ | $ |
As of January 01, 2024 | |||||||
Shares issued | |||||||
As of December 31, 2024 | |||||||
Shares issued | |||||||
Redesignation | ( | ||||||
Capital reduction | ( | ( | ( | ( | |||
As of December 31, 2025 |
Year Ended December 31, | ||||||
2025 | 2024 | 2023 | ||||
Employee restricted share unit program .................................................... | $( | $( | $( | |||
Business acquisition-related awards ........................................................... | ( | ( | ||||
Share warrants and share options ................................................................ | ( | ( | ( | |||
Direct share issuance ...................................................................................... | ( | ( | ||||
Share-based payment costs ............................................................................ | $( | $( | $( | |||
less: amounts recognized as reduction of revenue .................................. | $ | |||||
Share-based payments expense ..................................................................... | $( | $( | $( | |||
Klarna Group plc RSU program | Share warrants and options issued by Klarna Group plc | Share options to acquire C Class shares issued by Klarna Group plc | |||||||||
Number | Weighted average fair value at grant | Number | Weighted average exercise price1 | Number2 | Weighted average exercise price | ||||||
January 1, 2023 ....................... | $ | $ | $ | ||||||||
Granted during the year ...... | |||||||||||
Exercised during the year ... | |||||||||||
Forfeited during the year .... | |||||||||||
December 31, 2023 ................. | $ | $ | $ | ||||||||
Granted during the year ...... | |||||||||||
Exercised during the year ... | |||||||||||
Forfeited during the year .... | |||||||||||
December 31, 2024 ................. | $ | $ | $ | ||||||||
Granted during the year ...... | |||||||||||
Exercised during the year ... | ( | ||||||||||
Amended during the year3 .. | ( | ||||||||||
Forfeited during the year .... | ( | ||||||||||
December 31, 2025 ................. | $ | $ | $ | ||||||||
Legacy RSU program | Share warrants issued by a subsidiary of Klarna Group plc | ||||||
Number | Weighted average fair value at grant1 | Number | Weighted average exercise price2 | ||||
January 1, 2023 ...................................................................... | $ | $ | |||||
Granted during the year ..................................................... | |||||||
Released during the year ................................................... | ( | ||||||
Exercised during the year .................................................. | ( | ||||||
Forfeited during the year ................................................... | ( | ( | |||||
December 31, 2023 ............................................................... | $ | $ | |||||
Granted during the year ..................................................... | |||||||
Released during the year ................................................... | ( | ||||||
Exercised during the year .................................................. | ( | ||||||
Forfeited during the year ................................................... | ( | ( | |||||
December 31, 2024 ............................................................... | $ | $ | |||||
Granted during the year ..................................................... | |||||||
Released during the year ................................................... | ( | ||||||
Exercised during the year .................................................. | ( | ||||||
Repurchased during the year ........................................... | ( | ||||||
Amended during the year .................................................. | |||||||
Forfeited during the year ................................................... | ( | ( | |||||
December 31, 2025 ............................................................... | $ | $ | |||||
Equivalent of Klarna Group plc Shares | $ | $ | |||||
Share warrants and share options | |||||
2025 | 2024 | 2023 | |||
Expected volatility (%) ....................................................................................... | |||||
Risk-free interest rate (%) ................................................................................ | |||||
Expected term (years) ....................................................................................... | |||||
Weighted average share price for instruments issued by subsidiary of Klarna Group plc (in USD)1 ................................................................................ | N/A | ||||
Weighted average share price for instruments issued by Klarna Group plc (in USD) .............................................................................................. | N/A | ||||
Salaries and other remuneration to the board and senior management | 2025 | 2024 | 2023 | ||
Basic salary/fee ................................................................................................ | $ | $ | $ | ||
Fixed equity-based compensation ............................................................... | |||||
Variable equity-based compensation .......................................................... | |||||
Other variable-based compensation ............................................................ | |||||
Other benefits ................................................................................................... | |||||
Pension expenses ............................................................................................. | |||||
Total ..................................................................................................................... | $ | $ | $ |
Income tax (expense) benefit | 2025 | 2024 | 2023 | |||
Current tax | ||||||
Tax expense for the year ................................................................................ | $( | $( | $( | |||
Adjustment of tax attributable to previous years ...................................... | ( | |||||
Total ..................................................................................................................... | $( | $( | $( | |||
Deferred tax | ||||||
Deferred tax ....................................................................................................... | $( | $ | $ | |||
Total ..................................................................................................................... | $( | $ | $ | |||
Income tax (expense) benefit ........................................................................... | $( | $( | $ |
Effective tax rate | 2025 | 2024 | 2023 | |||
Profit (loss) before taxes ................................................................................. | $( | $ | $( | |||
Income tax calculated in accordance with national tax rates applicable in each country ............................................................................. | ( | ( | ||||
Non-taxable revenues ..................................................................................... | ||||||
Non-deductible expenses ............................................................................... | ( | ( | ( | |||
Taxable income not booked in profit or loss .............................................. | ( | ( | ( | |||
Deductible expenses not booked in profit or loss .................................... | ||||||
Unrecognized taxable losses ......................................................................... | ( | ( | ||||
Effect of change in tax rate ............................................................................ | ||||||
Losses carried forward recognized .............................................................. | ||||||
Adjustments of tax attributable to previous years .................................... | ( | |||||
Tax (expense) benefit ........................................................................................ | $( | $( | $ | |||
Effective tax rate ................................................................................................ | ( | ( |
Deferred taxes | December 31, 2025 | December 31, 2024 | ||
Deferred tax asset .......................................................................................................................... | $ | $ | ||
Deferred tax liability ....................................................................................................................... | ( | ( | ||
Total ................................................................................................................................................... | $ | $ | ||
Comprising: ...................................................................................................................................... | ||||
Losses carried forward ................................................................................................................. | ||||
Allowance for credit losses .......................................................................................................... | ||||
Intangible assets ............................................................................................................................. | ( | ( | ||
Other .................................................................................................................................................. | ||||
Total ................................................................................................................................................... | $ | $ |
2025 | 2024 | 2023 | ||||
Numerator: | ||||||
Net profit (loss) attributable to shareholders of Klarna Group plc ........ | $( | $ | $( | |||
Denominator: | ||||||
Weighted average number of ordinary shares - basic ............................. | ||||||
Dilutive potential ordinary shares ................................................................. | ||||||
Weighted average number of ordinary shares - diluted .......................... | ||||||
Net profit (loss) per share attributable to shareholders of Klarna Group plc: | ||||||
Basic .................................................................................................................... | $( | $ | $( | |||
Diluted ................................................................................................................. | $( | $ | $( |



